Operation parameters for CS systems [8].
\\n\\n
More than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\\n\\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\\n\\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\\n\\nAdditionally, each book published by IntechOpen contains original content and research findings.
\\n\\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\\n\\n\\n\\n
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'
Simba Information has released its Open Access Book Publishing 2020 - 2024 report and has again identified IntechOpen as the world’s largest Open Access book publisher by title count.
\n\nSimba Information is a leading provider for market intelligence and forecasts in the media and publishing industry. The report, published every year, provides an overview and financial outlook for the global professional e-book publishing market.
\n\nIntechOpen, De Gruyter, and Frontiers are the largest OA book publishers by title count, with IntechOpen coming in at first place with 5,101 OA books published, a good 1,782 titles ahead of the nearest competitor.
\n\nSince the first Open Access Book Publishing report published in 2016, IntechOpen has held the top stop each year.
\n\n\n\nMore than half of the publishers listed alongside IntechOpen (18 out of 30) are Social Science and Humanities publishers. IntechOpen is an exception to this as a leader in not only Open Access content but Open Access content across all scientific disciplines, including Physical Sciences, Engineering and Technology, Health Sciences, Life Science, and Social Sciences and Humanities.
\n\nOur breakdown of titles published demonstrates this with 47% PET, 31% HS, 18% LS, and 4% SSH books published.
\n\n“Even though ItechOpen has shown the potential of sci-tech books using an OA approach,” other publishers “have shown little interest in OA books.”
\n\nAdditionally, each book published by IntechOpen contains original content and research findings.
\n\nWe are honored to be among such prestigious publishers and we hope to continue to spearhead that growth in our quest to promote Open Access as a true pioneer in OA book publishing.
\n\n\n\n
\n'}],latestNews:[{slug:"stanford-university-identifies-top-2-scientists-over-1-000-are-intechopen-authors-and-editors-20210122",title:"Stanford University Identifies Top 2% Scientists, Over 1,000 are IntechOpen Authors and Editors"},{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"}]},book:{item:{type:"book",id:"8864",leadTitle:null,fullTitle:"Family Therapy - New Intervention Programs and Researches",title:"Family Therapy",subtitle:"New Intervention Programs and Researches",reviewType:"peer-reviewed",abstract:"This book is a collection of chapters written by a number of scientists from all over the world, who provide their insights not only into family therapy but also into new interesting interventions, programs, and research. The book adopts a perspective that respects the complexity of human beings and their family relationships. It devotes a space to the deepening of both psychological and social aspects: all themes in each section of the book are deeply connected. This book also focuses on some specific and really innovative topics, including the importance of psychosocial and family factors, complementary approaches, and relational aspects.",isbn:"978-1-78984-302-6",printIsbn:"978-1-78984-301-9",pdfIsbn:"978-1-83962-191-8",doi:"10.5772/intechopen.81558",price:119,priceEur:129,priceUsd:155,slug:"family-therapy-new-intervention-programs-and-researches",numberOfPages:164,isOpenForSubmission:!1,isInWos:null,hash:"e50bb9cef36aeaef4ba976554b3dd141",bookSignature:"Floriana Irtelli",publishedDate:"September 25th 2019",coverURL:"https://cdn.intechopen.com/books/images_new/8864.jpg",numberOfDownloads:3651,numberOfWosCitations:0,numberOfCrossrefCitations:2,numberOfDimensionsCitations:2,hasAltmetrics:1,numberOfTotalCitations:4,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 9th 2018",dateEndSecondStepPublish:"November 27th 2018",dateEndThirdStepPublish:"January 26th 2019",dateEndFourthStepPublish:"April 16th 2019",dateEndFifthStepPublish:"June 15th 2019",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,editors:[{id:"174641",title:"Dr.",name:"Floriana",middleName:null,surname:"Irtelli",slug:"floriana-irtelli",fullName:"Floriana Irtelli",profilePictureURL:"https://mts.intechopen.com/storage/users/174641/images/system/174641.jpeg",biography:"Floriana Irtelli is a psychoanalyst psychotherapist and IARPP member who has been lecturing for several years at the Catholic University of the Sacred Heart, Milan, Italy. She has worked at the Fatebenefratelli Hospital in Milan, performing research and clinical activities. She is among the authors of the books “A Fresh Look at Anxiety Disorders” and “Psychopathy - New Updates on an Old Phenomenon,” and has published articles for the Journal of Affective Disorders, the Journal Research in Psychotherapy, and the Journal for Psychiatric and Mental Health Nursing. She has participated in numerous conferences, seminars, and congresses. She is the sole author of the books “Illuminarsi di Ben-essere,” “Familiar-mente,” and “Contemporary Perspectives on Relational Wellness.”",institutionString:"Catholic University of the Sacred Heart",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"3",institution:{name:"Catholic University of the Sacred Heart",institutionURL:null,country:{name:"Italy"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"234",title:"Family Studies",slug:"psychology-family-studies"}],chapters:[{id:"66618",title:"A Chronological Map of Common Factors across Three Stages of Marriage and Family Therapy",doi:"10.5772/intechopen.85357",slug:"a-chronological-map-of-common-factors-across-three-stages-of-marriage-and-family-therapy",totalDownloads:437,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Hassan Karimi, Fred Piercy and Jyoti Savla",downloadPdfUrl:"/chapter/pdf-download/66618",previewPdfUrl:"/chapter/pdf-preview/66618",authors:[{id:"290630",title:"Dr.",name:"Hassan",surname:"Karimi",slug:"hassan-karimi",fullName:"Hassan Karimi"},{id:"290773",title:"Prof.",name:"Fred",surname:"Piercy",slug:"fred-piercy",fullName:"Fred Piercy"},{id:"290774",title:"Dr.",name:"Tina",surname:"Savla",slug:"tina-savla",fullName:"Tina Savla"}],corrections:null},{id:"65598",title:"Emotionally Focused Family Therapy: Rebuilding Family Bonds",doi:"10.5772/intechopen.84320",slug:"emotionally-focused-family-therapy-rebuilding-family-bonds",totalDownloads:1065,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Katherine Stavrianopoulos",downloadPdfUrl:"/chapter/pdf-download/65598",previewPdfUrl:"/chapter/pdf-preview/65598",authors:[{id:"281106",title:"Associate Prof.",name:"Katherine",surname:"Stavrianopoulos",slug:"katherine-stavrianopoulos",fullName:"Katherine Stavrianopoulos"}],corrections:null},{id:"66318",title:"Family Therapy: New Intervention Programs and Researches: Systemic Family Approach in Health Care",doi:"10.5772/intechopen.84582",slug:"family-therapy-new-intervention-programs-and-researches-systemic-family-approach-in-health-care",totalDownloads:487,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Hamilton Lima Wagner and Tania Dalallana",downloadPdfUrl:"/chapter/pdf-download/66318",previewPdfUrl:"/chapter/pdf-preview/66318",authors:[{id:"281898",title:"M.Sc.",name:"Hamilton",surname:"Wagner",slug:"hamilton-wagner",fullName:"Hamilton Wagner"},{id:"290304",title:"MSc.",name:"Tania",surname:"Madureira Dalallana",slug:"tania-madureira-dalallana",fullName:"Tania Madureira Dalallana"}],corrections:null},{id:"68320",title:"The DAVAd: A Narrative Tool to Explore the Early Stages of the Adoptive Bond",doi:"10.5772/intechopen.88329",slug:"the-davad-a-narrative-tool-to-explore-the-early-stages-of-the-adoptive-bond",totalDownloads:310,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Barbara Cordella, Paola Elia, Marzia Pibiri and Alessia Carleschi",downloadPdfUrl:"/chapter/pdf-download/68320",previewPdfUrl:"/chapter/pdf-preview/68320",authors:[{id:"290988",title:"Prof.",name:"Barbara",surname:"Cordella",slug:"barbara-cordella",fullName:"Barbara Cordella"},{id:"290992",title:"Dr.",name:"Paola",surname:"Elia",slug:"paola-elia",fullName:"Paola Elia"},{id:"290993",title:"Dr.",name:"Alessia",surname:"Carleschi",slug:"alessia-carleschi",fullName:"Alessia Carleschi"},{id:"290994",title:"Dr.",name:"Marzia",surname:"Pibiri",slug:"marzia-pibiri",fullName:"Marzia Pibiri"}],corrections:null},{id:"68306",title:"KidsTime Workshops: Strengthening Resilience of Children of Parents with a Mental Illness",doi:"10.5772/intechopen.87017",slug:"kidstime-workshops-strengthening-resilience-of-children-of-parents-with-a-mental-illness",totalDownloads:424,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Klaus Henner Spierling, Kirsty Tahta-Wraith, Helena Kulikowska and Dympna Cunnane",downloadPdfUrl:"/chapter/pdf-download/68306",previewPdfUrl:"/chapter/pdf-preview/68306",authors:[{id:"287221",title:"Mr.",name:"Klaus Henner",surname:"Spierling",slug:"klaus-henner-spierling",fullName:"Klaus Henner Spierling"},{id:"288316",title:"Dr.",name:"Kirsty",surname:"Tatah-Wraith",slug:"kirsty-tatah-wraith",fullName:"Kirsty Tatah-Wraith"},{id:"288320",title:"Mrs.",name:"Helena",surname:"Kulikowska",slug:"helena-kulikowska",fullName:"Helena Kulikowska"},{id:"308129",title:"Dr.",name:"Dympna",surname:"Cunnane",slug:"dympna-cunnane",fullName:"Dympna Cunnane"}],corrections:null},{id:"66457",title:"Mirage: Possibilities and Limitations of Experiencing Foster Home as a Family",doi:"10.5772/intechopen.85662",slug:"mirage-possibilities-and-limitations-of-experiencing-foster-home-as-a-family",totalDownloads:265,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Eva Mydlíková",downloadPdfUrl:"/chapter/pdf-download/66457",previewPdfUrl:"/chapter/pdf-preview/66457",authors:[{id:"284490",title:"Associate Prof.",name:"Eva",surname:"Mydlíková",slug:"eva-mydlikova",fullName:"Eva Mydlíková"}],corrections:null},{id:"67729",title:"Family Therapy: When the Adolescents’ Discourse is the Principal Resource",doi:"10.5772/intechopen.86366",slug:"family-therapy-when-the-adolescents-discourse-is-the-principal-resource",totalDownloads:254,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Silvia Renata Lordello",downloadPdfUrl:"/chapter/pdf-download/67729",previewPdfUrl:"/chapter/pdf-preview/67729",authors:[{id:"283776",title:"Dr.",name:"Silvia",surname:"Lordello",slug:"silvia-lordello",fullName:"Silvia Lordello"}],corrections:null},{id:"66010",title:"Group Process as a Resocialization Intervention: The Family - People Helping People Project",doi:"10.5772/intechopen.84876",slug:"group-process-as-a-resocialization-intervention-the-family-people-helping-people-project",totalDownloads:409,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"David F. Allen, Keva Bethell, Marie Allen-Carroll and Flavia D’Alessandro",downloadPdfUrl:"/chapter/pdf-download/66010",previewPdfUrl:"/chapter/pdf-preview/66010",authors:[{id:"280476",title:"Dr.",name:"David",surname:"Allen",slug:"david-allen",fullName:"David Allen"},{id:"280479",title:"MSc.",name:"Keva",surname:"Bethell",slug:"keva-bethell",fullName:"Keva Bethell"},{id:"280480",title:"Dr.",name:"Marie",surname:"Allen-Carroll",slug:"marie-allen-carroll",fullName:"Marie Allen-Carroll"},{id:"280481",title:"MSc.",name:"Flavia",surname:"D'Alessandro",slug:"flavia-d'alessandro",fullName:"Flavia D'Alessandro"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"7810",title:"Quality of Life",subtitle:"Biopsychosocial Perspectives",isOpenForSubmission:!1,hash:"0392d2712c58885b729bd943f9aac37f",slug:"quality-of-life-biopsychosocial-perspectives",bookSignature:"Floriana Irtelli, Federico Durbano and Simon George Taukeni",coverURL:"https://cdn.intechopen.com/books/images_new/7810.jpg",editedByType:"Edited by",editors:[{id:"174641",title:"Dr.",name:"Floriana",surname:"Irtelli",slug:"floriana-irtelli",fullName:"Floriana Irtelli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7117",title:"Psychosis",subtitle:"Biopsychosocial and Relational Perspectives",isOpenForSubmission:!1,hash:"3cfc852c7ecc10618bca94b1a559c9cd",slug:"psychosis-biopsychosocial-and-relational-perspectives",bookSignature:"Floriana Irtelli",coverURL:"https://cdn.intechopen.com/books/images_new/7117.jpg",editedByType:"Edited by",editors:[{id:"174641",title:"Dr.",name:"Floriana",surname:"Irtelli",slug:"floriana-irtelli",fullName:"Floriana Irtelli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"74026",slug:"corrigendum-to-calf-sex-influence-in-bovine-milk-production",title:"Corrigendum to: Calf-Sex Influence in Bovine Milk Production",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/74026.pdf",downloadPdfUrl:"/chapter/pdf-download/74026",previewPdfUrl:"/chapter/pdf-preview/74026",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/74026",risUrl:"/chapter/ris/74026",chapter:{id:"73504",slug:"calf-sex-influence-in-bovine-milk-production",signatures:"Miguel Quaresma and R. Payan-Carreira",dateSubmitted:"April 21st 2020",dateReviewed:"September 10th 2020",datePrePublished:"October 8th 2020",datePublished:"January 20th 2021",book:{id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,fullTitle:"Animal Reproduction in Veterinary Medicine",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"38652",title:"Dr.",name:"Rita",middleName:null,surname:"Payan-Carreira",fullName:"Rita Payan-Carreira",slug:"rita-payan-carreira",email:"rtpayan@gmail.com",position:null,institution:{name:"University of Évora",institutionURL:null,country:{name:"Portugal"}}},{id:"309250",title:"Dr.",name:"Miguel",middleName:null,surname:"Quaresma",fullName:"Miguel Quaresma",slug:"miguel-quaresma",email:"miguelq@utad.pt",position:null,institution:{name:"University of Trás-os-Montes and Alto Douro",institutionURL:null,country:{name:"Portugal"}}}]}},chapter:{id:"73504",slug:"calf-sex-influence-in-bovine-milk-production",signatures:"Miguel Quaresma and R. Payan-Carreira",dateSubmitted:"April 21st 2020",dateReviewed:"September 10th 2020",datePrePublished:"October 8th 2020",datePublished:"January 20th 2021",book:{id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,fullTitle:"Animal Reproduction in Veterinary Medicine",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"38652",title:"Dr.",name:"Rita",middleName:null,surname:"Payan-Carreira",fullName:"Rita Payan-Carreira",slug:"rita-payan-carreira",email:"rtpayan@gmail.com",position:null,institution:{name:"University of Évora",institutionURL:null,country:{name:"Portugal"}}},{id:"309250",title:"Dr.",name:"Miguel",middleName:null,surname:"Quaresma",fullName:"Miguel Quaresma",slug:"miguel-quaresma",email:"miguelq@utad.pt",position:null,institution:{name:"University of Trás-os-Montes and Alto Douro",institutionURL:null,country:{name:"Portugal"}}}]},book:{id:"8545",title:"Animal Reproduction in Veterinary Medicine",subtitle:null,fullTitle:"Animal Reproduction in Veterinary Medicine",slug:"animal-reproduction-in-veterinary-medicine",publishedDate:"January 20th 2021",bookSignature:"Faruk Aral, Rita Payan-Carreira and Miguel Quaresma",coverURL:"https://cdn.intechopen.com/books/images_new/8545.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"25600",title:"Prof.",name:"Faruk",middleName:null,surname:"Aral",slug:"faruk-aral",fullName:"Faruk Aral"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"7551",leadTitle:null,title:"Biotechnological Approaches in Plant Mutation Breeding",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tMutation breeding is one of the old breeding strategies to enhance the resistance of new plant varieties to biotic and abiotic stress factors. Nowadays, many plant biotechnology techniques such as plant tissue cultures, in vitro mutagenesis, in vitro selection, in vitro regeneration are used as a complement to classic mutation breeding. Plant biotechnology provides many advantages in terms of time, cost and labor in breeding process. Currently, many plant breeders use a combination of mutation and plant biotechnology techniques in their studies.
\r\n\tAt this point, it is important to review current developments in this area. In this book we will discuss the topics of radiobiology, in vitro mutagenesis, mutation breeding for resistance to biotic and abiotic stress factors, improved new crop varieties, metabolic pathways for antioxidant enzymes in plants, gene expression, omics approaches in mutation and image analyses studies in mutation breeding. This book intends to provide the reader with a comprehensive overview of the current developments in plant mutation breeding.
Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host, as defined by the World Health Organization [1]. This is an extremely broad definition that encompasses fungal and other eukaryotic species, as well as bacteria. In practice, however, bacterial probiotics receive the most attention. Bacterial probiotics can be found as various supplements and food additives in products such as pills and yogurts [2]. The benefits of probiotic supplements have been recognized for centuries, long before it was understood that the living microorganisms in the supplement provided the benefit. Fermented milk products were used as a treatment for intestinal discomfort in the Roman empire, and ancient Chinese scholars recommended fecal transplant to combat diarrhea [3]. Today, probiotics are often prescribed by gastroenterologists and GI surgeons to help alleviate irritable bowel syndrome, pouchitis, and functional diarrhea, however the potential applications of probiotics in other systems is gaining notice [4]. Yogurt and other fermented milk products as well as probiotic drink mixes are commonly used forms of probiotic supplements today [4].
Strains of the genera Bifidobacterium and Lactobacillus are the most common bacteria studied and used as probiotics, however Enterococcus, Streptococcus, Leuconostoc, Bacillus, and even the yeast Saccharomyces boulardii have been used [5, 6]. Knowledge of both the species and strain of bacteria is important in the study and use of probiotics as different strains can produce varying effects on the host. For instance, Escherichia coli Nessile 1917 is a beneficial probiotic while E. coli 0157:H7 is a deadly pathogen [2, 5]. Sources of probiotics vary. Probiotic bacteria are commonly found in fermented milk products, which lactic acid producing bacteria are essential to the production of, and they have also been isolated from stool samples of healthy individuals [5].
Probiotics can have a wide array of beneficial effects on their host organism (Figure 1). One way in which probiotics can benefit the host is to simply prevent or reduce the probability of infection by pathogenic organisms. By forming aggregates with intestinal pathogens, probiotics can reduce the ability of these pathogens to adhere to the intestinal mucosa and initiate infection [7]. Saccharomyces boulardii, Lactobacillus gasseri 4B2, and Lactobacillus coryniformis DSM 20001T have shown the ability to aggregate with pathogenic strains of E. coli (serogroup 0157:H7, and serogroup K88, respectively) [7, 8]. Probiotic bacteria can also increase mucin production in the gut, further reducing ability of pathogens to adhere to and infect host epithelial cells [9]. E. coli Nessile 1917 can upregulate the production of MUC2 and MUC3, the primary mucins present in the human colon [10]. Probiotic bacteria often have the ability to produce molecules damaging to pathogens, protecting the host organism by killing or inhibiting the activity of pathogenic bacteria. Several Lactobacillus strains produce antimicrobial bacteriocins, some examples include acidocin produced by Lactobacillus acidophilus, and sakacin produced by Lactobacillus sakei [11, 12]. These molecules may help the host maintain gut homeostasis by regulating the gut bacterial community. Several Lactobacillus species can inhibit the growth of Clostridium difficile or C. perfringens through the production of organic acids, and Lactobacillus plantarum LPAL and Bifidobacterium animalis ssp. lactis BLC1 produce some unknown bactericidal compounds or bacteriocins that inhibit both species [13]. Beneficial gut bacteria can also induce host immune cells to produce defenses against pathogens. Gut bacteria stimulate the production of an antibacterial, peptidoglycan-binding lectin in mice and in humans [14].
Schematic of possible mechanisms of probiotic interactions with molecules in the intestinal lumen as well as host epithelial cells.
Probiotics can also inhibit the growth of pathogens in other ways. Lactobacillus delbrueckii can bind iron to its surface, making it unavailable to pathogens, many of which need iron to survive [6]. Probiotics may also benefit the host by reducing the ability of pathogens to diffuse across epithelial cell barriers: strains of Lactobacillus show an ability to increase intestinal barrier function. Recent research has documented an increase in the levels of claudin-1 and goblet cells seen in healthy rats as well as in Lactobacillus johnsonii fed animals, suggesting that one aspect of the bacteria’s role in the gut is to strengthen the barrier function to prevent a leaky gut and maintain a high level of mucin production to protect the gut epithelial cells [15]. Lactobacillus johnsonii also appeared to increase the expression of inflammatory chemokines, including CCL20 (MIP3A), CXCL8 (IL-8), and CXCL10 (IP10) [16]. This result may indicate that exposure to beneficial Lactobacillus primes the gut immune system so that it is resistant to overwhelming inflammation in the face of later insults [16]. An increase in Paneth cells, immune cells in intestinal crypts, was also demonstrated in Lactobacillus fed animals [16]. Overall, probiotic bacteria, many in the genus Lactobacillus, can play an important role in defending the gastrointestinal tract from pathogenic organisms.
Probiotics can exert their positive effects on the host by producing vitamins or other materials useful to the host: Bifidobacterium adolescentis and B. pseudocatenulatum produce B vitamins including B1, B2, B3, B6, B8, B9, and B12 [6]. Probiotics may also increase the availability of nutrients already present in foods. Lactic acid bacteria increase the amount of available folic acid in fermented milk products [9]. The positive effects of Lactobacilli may also result from the bacterial production of esterases. These enzymes are produced by Lactobacilli and have the ability to release beneficial phenolic compounds, such as ferulic acid and caffeic acid, from food molecules [17]. Lactobacillus johnsonii N6.2, a strain associated with diabetes resistance in BioBreeding diabetes prone and diabetes resistant rats, produces two ferulic acid esterases that cleave ethyl ferulate and chlorogenic acid [17]. Other small molecules increased by probiotic bacteria can include free amino acids, and short chain fatty acids such as lactic acid, propionic acid, and butyric acid, which can be used by host cells for energy [9]. Some strains of Lactobacillus can produce hydrogen peroxide, which is beneficial to the gastrointestinal tract when present in small amounts [18]. In the case of host lactose intolerance, some strains of lactic acid bacteria, Streptococcus thermophilus, and Lactobacillus bulgaricus can aid in the host’s digestion of lactose by supplementing host lactase with their own [9]. Lactobacillus species can also increase the nutritional value of various food products. Fermentation with several Lactobacillus strains increased the dietary phenol available in cereal grains by a considerable amount [19]. Through both the synthesis and the breakdown of various substances, probiotics can improve host nutrition.
Probiotics have also shown promise in the area of cancer research. Lactobacillus casei and L. rhamnosus GG can reduce invasion in colon cancer cells, a key property in preventing metastasis [20]. Levels of matrix metalloproteinases, implicated in cell invasion, can be responsive to probiotic treatment: Lactobacillus acidophilus and L. rhamnosus GG can decrease the expression of matrix metalloproteinase-9 by increasing the expression of the tissue inhibitor of metalloproteinases [20]. Treatment with kefir reduces the viability of colon cancer cell lines by inducing apoptosis and the proliferation of colon cancer cell lines by arresting the cell cycle in the G1 phase [21]. These results suggest that probiotics may be useful in the treatment or prevention of some cancers.
Probiotics are commonly used for gastrointestinal complaints and issues, and there has been extensive research on the benefits of probiotics in this body system. Modern research often supports the old assertions that consumption of probiotics is beneficial to gastrointestinal health. Probiotic supplements have shown efficacy in treating certain intestinal disorders in animal models and in humans. Patients in remission from pouchitis who received probiotic treatment in the form of a bacterial supplement called VSL#3 showed increased Bifidobacterium and Lactobacillus diversity compared to patients receiving a placebo treatment [22]. Bifidobacterium and Lactobacillus are commonly regarded as beneficial members of the gut microbiota [23]. VSL#3 was also found to reduce the frequency of pouchitis recurrence [24]. This provides support for the use of probiotics in the treatment of GI diseases. A fermented soy probiotic mixture was shown to provide multiple gastrointestinal health benefits to rats with induced colitis. Rats fed the probiotic mixture of Bifidobacterium longum and Lactobacillus helveticus 416 had no colon damage, ulcers, or swelling, compared to rats who did not receive the probiotic supplement [25]. The rats receiving the probiotic also showed increased intestinal Lactobacillus and Bifidobacterium populations [25]. Supplementation with probiotics can help adjust the gut microbiota, and this likely plays a role in the effects of diseases of the gut. Apple juice fermented with Lactobacillus species showed the ability to inhibit Helicobacter pylori in vitro, but did not negatively affect other positive GI bacteria [26]. This further shows the ability some probiotics have to ameliorate disease-induced tissue damage and regulate the gut microbiota.
Probiotic supplements are no cure-all for gastrointestinal maladies, however. Assorted studies have reported little to no benefit of probiotics in the treatment of other gastrointestinal diseases. Lactobacillus probiotics were not shown to be an effective treatment in helping patients with Crohn’s disease stay in remission [27]. In a clinical trial involving women with irritable bowel syndrome, treatment with probiotics was not more effective than the administration of a placebo in reducing IBS symptom severity [28].
On the other hand, there is also a wealth of research showing probiotics to have benefits in areas of the body besides the adult gut. The importance of an individual’s microbiome is evident even before birth, therefore the prenatal and neonatal use of probiotics is an important consideration in infant health. The systemic benefits of probiotics can be transferred from mother to infant. In a study on allergies, a probiotic combination taken by an allergic mother, consisting of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12, decreased the probability of sensitization in breastfed infants, possibly by increasing the concentration of the anti-inflammatory cytokine transforming growth factor-beta 2 (TGF-β2) in breast milk [29]. Here we see the ability of a probiotic to induce immune changes in one organism that can be transmitted and positively affect the health of another.
Certain strains of bacteria have also been shown to reduce the negative effects of oral infections. In a study involving mice that were intubated with Lactobacillus gasseri SBT2055 and then infected orally with Porphyromonas gingivalis, the intubated mice showed less alveolar bone loss and better maintenance of the periodontal ligament than non-intubated mice [30]. In this case, pretreatment with probiotics helped prevent oral damage from infection. Probiotics may also help maintain or improve liver health. A probiotic mixture containing Bifidobacterium and Lactobacillus species reduced weight gain, maintained intestinal barrier function, and reduced liver inflammation in rats fed an inflammation-inducing high fat diet [31]. Another study using various Bifidobacterium strains corroborated these findings. B. pseudocatenulatum LI09 and B. catenulatum LI10 showed the ability to reduce D-GalN-induced liver damage and serum levels of inflammatory cytokines in rats [32]. Fang et al. found that supplementation with probiotics reduced levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), improved liver necrosis and inflammatory cell infiltration, reduced bacterial translocation to mesenteric lymph nodes, and reduced levels of interleukin 1β, macrophage inflammatory protein 1α, monocyte chemoattractant protein 1, and macrophage colony-stimulating factor in rats [32].
Probiotics have been used for centuries around the globe to improve health and treat disease. Although they are most commonly used to treat gastrointestinal diseases, they can exert positive effects on the health of the entire host organism. Although there has been much research elucidating how probiotics benefit their host and what benefits they actually provide, there is still much to be discovered about the many potential benefits of probiotics.
Inflammation is a complex immune response to many different insults, such as pathogens, cell death, and chemicals, which promotes survival during infectious diseases or injuries, as well as maintains tissue homeostasis. When an insult is identified, a cascade of signals is triggered, concluding in the recruitment of neutrophils and macrophages, which have the ability to produce several cytokines and chemokines. Despite the beneficial effects of inflammation, it must be tightly regulated, otherwise it may lead to serious tissue damage due the overproduction of inflammatory cytokines [33]. The secretion of cytokines is regulated at the transcriptional level, and many of them are also regulated at the posttranslational level [34]. Considering that the exposure to pathogens and chemicals is the first step in inflammation, the gastrointestinal environment has a crucial role in this process. Gut epithelial cells are the first cells to be exposed to both microbiota and food components, leading these cells to be key players influenced by food antigens, pathogens, toxins, and also by bodily metabolism and functions. Furthermore, the gut epithelial cells are the first line of defense against pathogens, complementing the action of the associated mucosal immune system, the development and maintenance of which are induced by the microbiota [35]. Some intestinal diseases are largely affected by the gut microbiota, such as inflammatory bowel disease (IBD), and Crohn’s disease (CD) [36].
The mechanisms to identify an insult and trigger an immune response may vary according the kind of the antigenic molecule. In order to identify different antigen molecules, the innate immune cells of mammals can detect these molecules through a fixed number of germline-encoded pattern recognition receptors (PRRs), which have the ability to recognize microbial structures called pathogen-associated molecular patterns (PAMPs), such as microbial nucleic acid and bacterial cell wall [37]. Furthermore, damaged host cells can release some molecules termed danger-associated molecular patterns (DAMPs), such as ATP, reactive oxygen species (ROS) and uric acid, which also have the ability to trigger PRRs [38]. Some PRRs are located in the cell membrane and endosomes and are called toll like receptors (TLRs) and C-type lectin receptors (CLRs), which are able to recognize PAMPs and DAMPs located in the extracellular milieu. The other class of receptors is the NOD-like receptors (NLRs), which are located inside the cell in the cytoplasm [39].
TLRs were first characterized by Christiane Nusslein-Volhard in 1985, when she observed that the protein encoded by Toll gene was responsible for preventing the dorsoventral patterning in Drosophila embryos [40]. Later, it was observed that TLRs trigger a specific response for different microbes, ending up in the activation of specific regulatory pathways [41]. To date, several TLRs have been classified in mammals and theirs targets identified. Highly conserved, TLRs belong to type 1 transmembrane glycoproteins and are composed of three main structural components: a leucine-rich motif for ligand recognition at N-terminus; a single transmembrane helix; and a cytoplasmic Toll/interleukin-1 (IL-1) receptor domain at C-terminus, as reviewed by Gao and co-workers [42]. TLRs can be expressed on cell membrane, as well as on endosomal membrane. The TLRs expressed on cell membrane are TLR1, TLR2, TLR4, TLR5, TLR6, TLR10, TLR11 and TLR12, whereas TLR3, TLR7, TLR8, TLR9 and TLR13 are expressed on endosomal membrane [43]. Each TLR specifically binds to microbial molecules, triggering a cascade of signals that result in the transcription and production of pro-inflammatory cytokines and chemokines. TLR4 is one of the most studied TLRs due its ability to detect lipopolysaccharide (LPS), leading to the activation of both myeloid differentiation antigen 88 (MyD88)-dependent and MyD88-independent pathways [44]. Downstream, MyD88 is responsible for the activation of the master transcriptional regulators MAPK and NF-κB, which increase transcriptional expression of IL-1β, IL-6, IL-8 and IL-18 [45].
Like TLRs, NLRs can sense different molecules and trigger an inflammatory response. NLRs also have a structure composed of three main domains: caspase recruitment domain (CARD) or pyrin domain (PYR) at N-terminal; the highly conserved NATCH domain, a nucleotide-binding domain (also called as NBD); and leucine-rich repeats (LRR) at the C-terminal [46]. Based on the N-terminal domain, NLRs are subdivided into 8 sub-families (Figure 2). The LRRs are responsible for microbial molecule detection, whereas the CARD and PYD domains are responsible for homotypic and heterotypic interactions of NLRs with downstream molecules, such as pro-caspase, directly or via the adaptor molecule, apoptotic-associated speck like protein (ASC) [47].
NLRs families and triggering of the inflammasome. (A) NRRs currently known families, showing the highly conserved NACHT domain; (B) differences between ASC-dependent and ASC-independent binding to caspase-1; (C) schematic activation of the inflammasome.
Once epithelial cells recognize PAMPs or DAMPs, many different responses can be triggered in order to eliminate the source of those molecules. One well-known response against pathogens is called the inflammasome. Inflammasomes are a multiprotein complex formed in response to PAMPs and DAMPs, resulting in the activation of caspase-1 (canonical pathways) or caspase-11 (non-canonical pathway) [48]. NLRs located in the cytosol act as sensors of these microbial molecules, leading to the activation of the inflammasome complex. The inflammasome is basically composed by the NLR family members, which may contain the PYR domain or just the CARD, and by the adapter ASC. ASC has both CARD and PYD domains, and the association between ASC and CARD-containing NLRs recruits caspase-1 via homotypic interactions [49]. Despite around 23 NLR genes having been identified to date, only some of them can form oligomeric complexes which end up in the post-translational activation of caspases [50]. The hallmark of the inflammasome is the recruitment of caspase-1 in the canonical pathway, which is further released and subsequently activated via auto cleavage. Active caspase-1 can cleave and activate more than 70 substrates. This sequential process will finally release active caspase-1 to activate the IL-1β cytokine and gasdermin-D to promote adaptive and humoral immunity (Figure 2) [51]. In the non-canonical pathway, cleavage and activation of interleukins can also occur via caspase-4/caspase-5 (humans) or caspase-11 (rodents) [52].
Despite the fact that caspase-1 is a protein that plays an important role in many different pathways, one of the most studied ones is pyroptosis, which is a cell death caused by inflammation in response to microbial infections or nonmicrobial stimuli [53]. In pyroptosis, caspase-1 is activated through inflammasome assembly and its active form can then cleave gasdermin-D (GSDMD) at Asp276, which generates the N-terminal cleavage product (GSDMD-NT) triggering pyroptosis and cell death. GSDMD-NT has the ability to form pores on the cell membrane, leading to cell leakage and the release of pro-inflammatory cytokines [54]. Moreover, active caspase-1 can also cleave pro-interleukin-1β (pro-IL-1β) and pro-interleukin-18 (pro-IL-18) into their active form. IL-1β is a pyrogenic cytokine that can promote adaptive and humoral immunity. Neither IL-1β nor IL-18 are secreted by the endoplasmic reticulum-Golgi route. Nevertheless, IL-18 is constitutively expressed in macrophages, whereas IL-1β expression is regulated by NF-κB-mediated transcription [48]. There are other signals that can also trigger the auto-cleavage of pro-caspase-1 independent of NLRP3 activation. Some examples of these secondary signals are ROS and unfolded proteins [55].
The gastrointestinal system harbors a diverse and complex microbial community that has a pivotal role in host health. However, changes in the microbiota population can have major consequences, beneficial or harmful, for host health. The disruption of the gut microbiota, called dysbiosis, has been observed in several pathological conditions such as obesity, diabetes, and IBD, encompassing ulcerative colitis (UC) and CD [56, 57]. In humans, susceptibility to type 1 diabetes has been associated with changes in the gut microbiota composition, with a significant augmentation of bacteria of the Bacteroidetes phylum, and lower concentrations of Bifidobacterium, Lactobacillus, and Clostridium strains [58]. The search for probiotic strains that can reestablish host health has strongly increased in the past decades. Most of the microflora of healthy hosts is composed of bacteria from four bacterial phyla: Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria [59]. The genus Lactobacillus belongs to the Firmicutes phylum, which explains the large amount of studies with Lactobacillus species being administered as probiotics.
The inflammasome has been considered as an important regulator of intestinal homeostasis, due the central role of IL-1β and IL-18 in Th1 responses by the induction of IFNγ [60]. Moreover, IL-1β is responsible for induction of neutrophil influx, activation of myeloid cells and lymphocytes, and stimulation of Th17 differentiation [61]. Despite the fact that activation of inflammasomes increases the maturation of the pro-inflammatory cytokines IL-1β and IL-18, there is some evidence that the inflammasomes are important for keeping intestinal homeostasis and reducing morbidity and mortality in dextran sulfate sodium (DSS)-induced colitis in mice. It has been shown that mice deficient in some NLRs, such as NLRP1, NLRP3, NLRP6, NLRP12, AIM2, or deficient in ASC exhibited higher levels of pro-inflammatory mediators, as well as an increase in the epithelial damage within the colon, as reviewed by Chen [60]. Surprisingly, the severity of DSS-induced colitis seems to be reduced when antibiotic therapy is provided to mice, which strongly suggests the role of the gut microbiota in the phenotype of inflammasome-deficient mice [62]. This result was also observed in another experiment where inflammasome-deficient mice were cohoused with wild-type mice or with mothers of the opposite phenotype. After some days living together, an increase in colitis transmissibility through microbial transfer was observed.
The mechanism by which inflammasomes can affect the gut microbiota composition is still unclear. However, the effects of IL-18 on the production of antimicrobial peptides (AMPs) have revealed a possible explanation. IL-18 is able to upregulate the production of AMPs, which is crucial for microbial clearance [63]. Asc−/−, caspase-1−/−, AIM2−/−, or Nllrp6−/− mice have shown lower levels of AMPs when compared with WT, but normal levels of specific AMPs are restored after the administration of recombinant IL-18 [60]. Considering that AMPs can be produced to target a specific microbe, the modulation of AMP production can contribute to the abundance of certain bacterial populations. Administration of Ang4, a well characterized AMP, into Asc−/− mice changed the overall diversity and community of gut microbiome, but it was still significantly distinct from the WT mice [63]. All these data suggest that despite the activation of the inflammasome increasing the release of pro-inflammatory cytokines, shutting down this pathway also contributes to undesired inflammation. Thus, the modulation of the inflammasome seems to be a key factor in the prevention of exaggerated inflammation.
Many studies have focused on the use of probiotic strains that could avoid or ameliorate inflammation. One promising treatment for IBD is the commercially available probiotic mixture VLS#3, which is a mixture of eight strains of lactic acid-producing bacteria (Lactobacillus plantarum, Lactobacillus delbrueckii subsp. Bulgaricus, Lactobacillus casei, Lactobacillus acidophilus, Bifidobacterium breve, Bifidobacterium longum, Bifidobacterium infantis and Streptococcus salivarius subsp. Thermophilus). VLS#3 has been shown the ability to ameliorate and prevent colitis in the Il10−/− murine model [64]. The mechanisms by which VLS#3 can reduce intestinal inflammation are still unclear, but several independent results have shown the effects of VLS#3 on the gastrointestinal tract. It was observed that the administration of VLS#3 decreases the biodiversity of the luminal microbiota on TNBS-induced chronic colitis rats [65]. Moreover, TNBS-induced colitis rats treated with VLS#3 have demonstrated pro-inflammatory cytokine and chemokine levels similar to the levels observed in normal rats [66]. These results are in agreement with the effects of VLS#3 observed on the inflammasome of NOD mice: decreasing the mRNA levels of Il1b and increasing the mRNA levels of Ido, an immunomodulatory enzyme, comparable to control group levels [67]. Surprisingly, VLS#3-treated NOD mice also reduced effective T cells/regulatory T cells (Teff/Treg) ratios at both systemic and pancreatic lymph nodes levels, helping in the maintenance of the immune homeostasis and avoiding excess inflammation.
Due to the proximity of the vaginal mucosa to the gastrointestinal system, the vaginal microbiota is largely affected by the gut microbiota, being dominated by Lactobacilli [68]. Recently, Lactobacillus rhamnosus GR-1 has been reported to be able to limit Escherichia coli-induced inflammatory response in Bovine Endometrial Epithelial Cells [69]. It was observed that L. rhamnosus reduces inflammation by downregulating Tlr2, Tlr4, Nod1 gene expression, as well as the downregulation of Myd88 and Nfkb mRNA levels. Moreover, this strain showed the ability to reduce mRNA levels of the main components of the inflammasome: NLRP3, ASC, and Caspase-1. Consequently, the mRNA levels of the pro-inflammatory cytokines IL-1β, IL-6, IL-8, IL-18, and TNFα where suppressed by L. rhamnosus.
The activation of the inflammasome seems to not be dependent on bacterial viability or require phagocytosis, but the potassium efflux seems to be crucial. A study with bone marrow-derived macrophages (BMDMs) incubated with heat-killed B. infantis did not show an increase in the IL-1β levels when compared to cytokine levels when BMDMs were incubated with live bacteria. However, when the cells were incubated with heat-killed bacteria overnight, the IL-1β levels were similar to the levels observed when incubated with live bacteria [70]. In the same work, it was observed that using cytochalasin D, a phagocytosis inhibitor, did not significantly change the IL-1β levels. Interestingly, when WT macrophages were incubated with high concentrations of potassium or with the potassium channel blocker ruthenium red, the levels of IL-1β were significantly lower in response to B. infantis or B. fragilis, suggesting that the activation of NLRP3 inflammasome is dependent on potassium efflux.
The modulation of the inflammasome by probiotics or gut microbiota does not only affect the gastrointestinal system. In fact, the gut microbiota can modulate the inflammasomes and its effects systemically. The concentrations of pro- and anti-inflammatory cytokines have been correlated with some neurological pathologies, such as depression, which is characterized by high levels of pro-inflammatory cytokines (i.e. IL-1β and IL-6) and low levels of anti-inflammatory cytokines (i.e. IL-4 and IL-10) [71]. Moreover, more IL-1 receptor type-I and its ligands have been found to be highly expressed in brain areas related to stress response, and chronic stress and the administration of IL-1β have been characterized as triggers of depression-like behavior [72]. Nevertheless, higher levels of caspase-1 and NLRP3 mRNA have been observed in blood cells of depressed patients, which suggests that the inflammasome pathway may play a key role in the development of depression [73]. Casp1−/− mice showed decreased depressive and anxiety-like behaviors after a forced swim test compared with WT mice [74]. The effects of chronic restraint stress assay, which increases the caspase-1 and IL-1β levels, also resulted in altered gut microbiota compared to non-stressed mice. The relative abundances of the genera Allobaculum, Bifidobacterium, Turicibacter, Clostridium, and the family S24-7 were significantly reduced in restrained animals, whereas the abundance of the family Lachnospiraceae showed an increase. Bifidobacterium spp. is a genus associated with the suppression of inflammation by the inhibition of the nuclear factor-κ-B (NF-κB) pathway [75]. All these findings strongly support the notion that the inhibition of caspase-1 can reduce the stress response by modulating the interface between stress and the gut microbiota, and that the gut microbiota can exert some important effects on brain function via the inflammasome signaling.
In the past decade, many studies have demonstrated the effects of the gut microbiota on metabolic diseases. In comparing the gut microbiota of two distinct kinds of rats, the Biobreeding Diabetes Prone (BB-DP) and the Biobreeding Diabetes Resistant (BB-DR) rats, a higher abundance of Lactobacillus and Bifidobacterium species was identified in BB-DR stool samples [56]. One of the most prevalent species found in this work was Lactobacillus johnsonii, which was isolated from the stool of BB-DR rats. L. johnsonii has two cinnamoyl esterases that utilizes many phenolic compound as substrates [17]. One well known substrate is rosmarinic acid (RA), a phenolic compound extracted from diverse kinds of plants from the Nepetoideae subfamily of the Lamiaceae family [76]. These cinnamoyl esterases can cleave RA into its two components, caffeic acid (CA) and 3,4-dihydroxyphenylactic acid (DOPAC). Both RA and its components are well known for their antioxidant and anti-inflammatory properties [77, 78]. Based on the activity of the cinnamoyl esterases on RA, a recent study compared the effects of L. johnsonii N6.2 when administrated alone or in combination with RA on the inflammasome pathway in the ileum tissue of BB-DP rats fed daily with these treatments. It was observed that, despite higher levels of caspase-1 mRNA and higher levels of pro-caspase-1 in the rats fed with L. johnsonii N6.2, this strain decreased the concentration of the active caspase-1, compared to the animals fed with RA alone or in combination with the bacterium [79]. In the same study, it was observed that only RA significantly induced the expression of the Il1b gene, 12.5-fold compared to the PBS control. Consequently, RA-fed rats accumulate higher amounts of total IL-1β in the tissue. Lower levels of the pro-inflammatory cytokines TNFα and IFNγ were also observed in BB-DP rats fed with L. johnsonii N6.2 [80]. A similar result was observed in dogs with chronic enteropathy (CE) that were treated ex-vivo and in-vivo with Enterococcus faecium [81]. It was observed that ex-vivo stimulation of duodenal biopsies with E. faecium increased the mRNA levels of caspase-1 in CE dogs. However, the protein levels of IL-1β was significantly reduced after treatment. Moreover, L. johnsonii N6.2 demonstrated to be able to produce H2O2, which has an inhibitory effect on the enzyme indoleamine 2,3-dioxygenase (IDO). IDO is the rate-limiting enzyme of tryptophan catabolism, converting tryptophan into L-kynurenine. The accumulation of cytotoxic kynurenines due to higher IDO activity can result in localized immunosuppression [82]. All these anti-inflammatory activities of L. johnsonii N6.2 along with its ability to modulate the host immune responses may explain the mitigation of type 1 diabetes in BB-DP rats when fed daily with this bacterium [15, 83].
Like any living thing, a cell’s main goal is to grow, proliferate, and ultimately, survive. This requires the coordination of multiple environmental signals, working synergistically through several pathways in order to culminate into a common outcome. Intricate organization and intracellular crosstalk is necessary for this to be accomplished. Often, these coordinated signals require a regulator to ensure that these functions are carried out efficiently. For most of these processes, the mechanistic target of rapamycin (mTOR) could be considered that important moderator. mTOR is a serine/threonine kinase that presents itself into two distinct complexes: mTORC1 and mTORC2. Ultimately, this pathway integrates external and internal cues to encourage a cell to grow, proliferate, and survive. It senses a diverse set of nutritional and environmental stimuli, including growth factors, amino acids, energy levels, oxygen and stress in order to stimulate anabolic cellular processes like protein and lipid synthesis, and to discourage catabolic processes like autophagy. Deregulation of this pathway has been heavily linked to metabolic disorders and cancer [84].
As of today, mTORC1 is better characterized out of the two mTOR complexes. This complex is composed of three core proteins and two inhibitory proteins as follows: mTOR, Raptor (regulatory protein associated with mTOR), mLST8 (mammalian lethal with Sec13 protein 8), DEPTOR (DEP domain containing mTOR interacting protein), and PRAS40 (proline-rich AKT substrate of 40kDA) [85]. A popular path to mTORC1 activation is through PI3K/AKT [86]. Here, growth factors and hormones bind to their receptor and activate the intracellular phosphatidylinositide 3-kinase (PI3K) which, through multiple interactions, leads to phosphorylation and partial activation of protein kinase B (AKT). AKT activation phosphorylates and consequently inhibits the tuberous sclerosis complex (TSC). This inactivation stimulates mTOR by inactivating Rheb’s (Ras homolog enriched in brain) GTPase domain so that active GTP-bound Rheb binds to mTOR.
Activation of mTORC1 leads to an increase in protein synthesis, lipid biosynthesis, and a decrease in autophagy [85]. Downstream, mTORC1 promotes protein synthesis essentially through two main effectors: p70S6 kinase 1 (S6K1) and eIF4E binding protein (4EBP). S6K1 can also influence lipid biosynthesis by activating the sterol responsive element binding protein (SREBP), which promotes the transcription of genes involved in fatty acid and cholesterol biosynthesis [87]. However, this transcription factor can also be activated by mTORC1, by inhibiting Lipin1, a protein the keeps SREBP localized to the cytoplasm [88]. Peroxisome proliferator-activated receptor 𝛾 (PPAR𝛾), a main regulator of adipogenesis, is also activated by mTORC1 [89]. Autophagy is inhibited by mTORC1 through the inhibition two main effectors: ULK1 and DAP1 [90]. ULK1 is a kinase that forms a complex with other proteins required for autophagosome formation while DAP1 directly negatively regulates autophagy.
Even though mTORC2 still holds many secrets, we do know a bit about the complex and the functions it regulates. Along with mTOR itself, this second mTOR complex also contains mLST8 and DEPTOR. However, instead of Raptor, mTORC2 contains Rictor (rapamycin-insensitive companion of mTOR), mSIN (mammalian stress-activated map kinase interacting protein 1) and protor 1/2 (protein observed with Rictor 1 and 2) [85]. While mTORC1 is known to be affected by many external stimuli, mTORC2 is resistant to nutrients but is affected by growth factors through a mechanism requiring PI3K. Though this mechanism is poorly understood, it may require the use of ribosomes as ribosomes are needed for mTORC2 activation via a PI3K-dependent process [91].
Not much is known about mTORC2 activation and downstream studies do not hold many answers either. It does seem to primarily control cell survival and proliferation. It is known that when mTORC2 is activated it phosphorylates and fully activates AKT by phosphorylating at serine473 [92]. This mTORC2-dependent phosphorylation unlocks the AKT functions of inhibiting transcription factors FoxO1/3a, which regulates energy metabolism and apoptosis [93]. However, this phosphorylation is not required for AKT inhibition of the TSC complex, therefore mTORC1-dependent functions are not affected. mTORC2 can also directly phosphorylate SGK1, a kinase that controls ion transport and also inhibits FoxO1/3a [94]. Lastly, mTORC2 also regulates cytoskeletal dynamics through the activation of paxillin, PKC-α, and Rho GTPases, ultimately affecting cell shape and migration [95].
Since the mTOR pathway is heavily involved in functions affecting survival and growth and responds to growth factors, energy status, amino acids and oxygen, it is not at all surprising that deregulation of this pathway can cause serious systemic problems. Indeed, mTOR is a very complex pathway that seems to play a central role in many fundamental cellular processes. Since new mechanisms of action and regulation are constantly being discovered, it seems that this pathway still has many secrets to be told. Due to the importance of the functions mTOR controls, it is extremely important to keep this pathway in-check. Certainly, this pathway does contain intricate negative feedback loops and inactivating enzymes to prevent the pathway from going into a chronic state of activation. However, like all well-organized systems, a simple flaw could wreak havoc on the system, and there have been plenty of cases reported in disease and research of the consequences that occur in these circumstances.
Since the mTOR pathway integrates glucose homeostasis and lipid synthesis, it is not difficult to believe that disruptions in this pathway can lead to serious metabolic diseases. Indeed, mTOR has been heavily involved in obesity-related comorbidities, such as type 2 diabetes. A high fat diet, a contributing factor to these diseases, has been known to raise insulin, amino acids, and pro-inflammatory cytokines levels, which can affect mTOR activity. Type 2 diabetes occurs when cells become immune to insulin, even when sufficient insulin levels accumulate to signal cells to take up glucose. mTORC1 has been implicated in regulating the insulin-producing pancreatic β cell function, as β cell-specific TSC component knockout mice revealed that young mice experienced increased β cell mass coordinated with higher insulin levels and increased glucose tolerance [96]. However, as the mice aged, these observations reversed, resulting in a decline of β-cell function over time [97]. This biphasic display could be explained through the feedback inhibition of insulin/PI3K/AKT by constitutive S6K1 expression [98]. At first, constant mTORC1 expression improves β-cell function, however this constant activation eventually accumulates in the S6K1-mediated inhibition of IRS1 upstream of mTORC1. Decrease in β cell function is also observed when mTORC2 signaling is knocked out. In this case, activation of AKT does not occur, which encourages FoxO1 activation. This causes a defect in glucose metabolism, leading to glucose intolerance due to a reduction in β-cell mass and proliferation, affecting insulin production and secretion [99]. It is clear that mTOR is a major regulator in β-cell viability and insulin signaling. Deregulation of this pathway has a great potential to cause insulin resistance leading to diabetes onset.
mTOR signaling also plays a significant role in obesity and non-alcoholic fatty liver disease, both of which can be characterized by an increase in adipogenesis. Fat, the most important energy storage site, accumulates in an mTORC1-activated state, while loss of mTORC1 results in leanness and resistance to high fat diet-induced obesity through enhanced mitochondrial respiration [100, 101]. This is because downstream effectors of mTORC1, 4E-BP and S6K1, regulate adipogenic transcription factors and their translation [102, 103]. Loss of mTORC2, on the other hand, results in impaired glucose transport in response to insulin stimulation and increased lipolysis translating to an escalation in circulating free fatty acids and glycerol [104]. Proliferation of adipose tissue is recognized to be the highest risk factor in developing obesity-related diseases. Over-activation of mTOR has been heavily connected in the tissues of obese and high fat diet-fed animals and its regulation is critical in maintaining a healthy state.
The liver is a multifaceted organ. Not only does it filter and detoxify the blood, it also produces and stores compounds utilized by the whole body. Of importance to this discussion, the liver is responsible for producing triglycerides, cholesterol, and ketone bodies that peripheral organs use as an energy source in low nutrient states. Like adipose tissue and pancreas, mTORC1/S6K1 activity in the liver is high in obese or nutrient dense states, leading to feedback inhibition of IRS and insulin resistance. This inhibition leads to the hyperglycemia and hyperinsulinemia characteristic of type 2 diabetes and insulin resistance. Interestingly, in the liver as well as other tissues, insulin loses its sensitivity yet still retains its ability to stimulate fatty acid synthesis. This could be explained by the fact that FoxO1 in primarily responsible for glucose metabolism in an mTORC2-dependent process, while mTORC1 promotes lipogenesis and this is primarily controlled via SREBP expression [105, 106]. Therefore, this may promote the double-edged sword of glucose intolerance and the stimulation of lipogenic processes, leading to obesity and insulin resistance in an mTOR-dependent manner.
Lastly, imperfect mTOR signaling plays an important role in many cancers. This pathway is made up of many proto-oncogenes and tumor suppressors that, if affected, could turn a cell into a constitutively growing and proliferating state characteristic of cancers. PTEN (phosphatase and tensin homolog) antagonizes the actions of PI3K, which phosphorylates phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-trisphosphate (PIP3). PTEN recycles PIP3 back to PIP2, blocking downstream PI3K/AKT/mTOR signaling. Mutations in this gene blocks the ability of PTEN to recycle PIP3 and deactivate downstream effects, and it has been found to be frequently mutated in human cancers [107]. Another tumor suppressor, TSC1/2, suppresses chronic mTOR activation but, when mutated, can lead to abnormal and unregulated growth [108]. Hyperactivation of mTOR can also happen at the genomic level, as mutations in MTOR have also been found in various cancers [109]. Other oncogenic genes, such as Akt, Pi3k, and Rheb, have been described to encourage proliferation and tumor progression. Many of the pathways genes and proteins have been credited with encouraging a proliferative state when manipulated, and since the mTOR pathway is so vast and largely unknown, pinpointing the problem becomes an impossible feat. Even more challenging is finding treatments that are effective and do not have downstream adverse effects.
In response to stimulatory signals, such as insulin and nutrients, the combination of increased adiposity and insulin resistance resulting from chronic mTOR activation is the main driving factors contributing to metabolic disease. To further complicate the scene, genetic mutations or aberrantly functioning proteins can force a cell into a constitutively growing and dividing unit, reminiscent of cancer. Cancer and metabolic disorders are some of the most common diseases in modern times. To contain or prevent the occurrences of these diseases are the topics of many current research and clinical trials. The mTOR pathway coordinates cell growth and environmental conditions through an intercalated network that must adapt to unstable conditions. The complexity of this pathway, the diverse signals it recognizes, and the importance of the functions it regulates makes this a promising, albeit cumbersome, target for therapeutic intervention.
Although no studies have directly explored the interaction of probiotics with the mTOR pathway, it is likely to surface soon. With the microbiome a popular topic in research in relation to disease onset and now the emergence of mTOR as a main regulator of essential cellular functions whose deregulation is indicated in disease, it would be not all too surprising if a connection could be made between the two. To be able to implement a non-invasive strategy to treat diseases such as cancer or type 2 diabetes would be a huge leap forward in medical technology. Indeed, a main goal in microbiome research is to be able to understand the effects of these microorganisms in the gastrointestinal context, and to dissect their interactions with the host and their environment, including other microbial species and luminal contents. Though many groups have reported on some of the effects of specific microbial species, there is still much left to be discovered. Here, we will consider some of the connections these effects may have with the mTOR pathway (Figure 3), and discuss the potential consequences this may have on the host.
A simple representation of the mTOR pathway and some potential probiotic targets. External signals such as inflammation, growth factors, insulin, and amino acids can stimulate mTOR activity through a cascade of upstream effectors. These can activate processes that are required for a cell to grow, proliferate and survive. Using probiotics to target some of these stimulatory signals or enzymes within the pathway can help modulate its effects regarding disease onset.
In many cases, disease onset is preceded by a systemic inflammatory response. This is also the case in cancer and metabolic disorders. As mentioned, inflammatory cytokines, such as TNFα, are known to be potent inducers of mTOR activity. TNFα is known to inhibit TSC1 through its activation of IKKβ, a link that has also been exposed in tumor angiogenesis [110]. A significant elevation of pro-inflammatory cytokines has also been described to be associated with metabolic disorders, such as obesity and type 2 diabetes. As is the case with cancer, IKKβ seems to also link inflammation to obesity-induced insulin resistance, and its inhibition could potentially be used to treat insulin resistance [111]. Coincidentally, numerous studies on probiotic strains have focused on alleviating inflammation and have even reported this to be correlated with reduced disease onset [15, 112]. Reducing the circulation of inflammatory cytokines will be less effective in activating IKKβ and therefore stimulating mTOR activity. Therefore, the successful alleviation of inflammatory cytokines with probiotics has the potential to reduce the activation of mTOR and its downstream effects, potentially reducing the incidence of modern diseases associated with chronic mTOR activation.
Insulin resistance occurs when the hormone insulin is insufficient in triggering cells to take in glucose to be converted into energy. Although insulin is produced at reasonable levels, glucose cannot enter the cells and therefore builds up in the blood, leading to hyperglycemia. Both insulin resistance and hyperglycemia are characteristic of type 2 diabetes, and it has been explained that chronic mTOR activation can contribute to this through the negative feedback loop connecting S6K1 to IRS. Obesity and a poor diet have also been described to be risk factors for type 2 diabetes, and associated with mTOR activity. Since the occurrence of type 2 diabetes is dramatically increasing and it continues to be one of the most prevalent diseases threatening human health, there have been many studies commenting on probiotic intervention to reduce symptoms of type 2 diabetes. Several Bifidobacterium and Lactobacillus strains are described to reducing weight gain, improving insulin-glucose homeostasis and overall improving metabolic syndrome in obese or high fat diet-fed mice [113, 114]. Even a study on a probiotic yeast was found to reduce metabolic syndrome symptoms and hepatic steatosis in obese and diabetic animals [115]. Clinical studies are now investigating this relationship and have reported improved insulin resistance in high fat, over-fed circumstances [116, 117]. However, these studies have rarely looked directly at the mechanism in which these probiotics contribute to human health, and even less often have any investigated into the effects on mTOR. Needless to say, it is possible that these mechanisms could be mTOR-mediated, however more work into this area is needed.
One of the many benefits that our microbial symbionts provide for us is the ability to produce or release substances that our bodies are not capable of doing itself. These substances include vitamins, antimicrobials, butyrate, and other short chain fatty acids (SCFA). In fact, even the famous inhibitor in which the pathway is named after, rapamycin, is produced by the bacterium Streptomyces hygroscopicus, providing more evidence that microbes can make specific ligands that interfere with the activity of mTOR enzymes. Studies have elucidated the beneficial effects of butyrate have on colon diseases, such as ulcerative colitis, Crohn’s disease, and cancer [118]. To date, two main SCFA signaling mechanisms have been described: the inactivation of histone deacetylases (HDAC) and the stimulation of G-protein-coupled receptors. One study has even uncovered the role of HDAC-activated S6K1 in promoting immune tolerance through T-cell differentiation into effector and regular T cells due to SCFAs [119]. This response is important when cells are faced with a potent stimulus. Instead of over reacting to the stimuli, the T cells emit tolerant signals to be able to neutralize the threat instead of creating a systemic inflammatory response. Additionally, some probiotic strains encode for unique enzymes that can cleave off phenols, or natural antioxidants, from dietary fiber [17, 120, 121]. Coincidentally, many of the inhibitors of the mTOR pathway, such as the popular rapamycin and its derivatives, are cyclic and phenolic in nature. This opens up a new avenue of research, exploring natural food components released by probiotics in controlling pathways whose deregulation is associated with diseases. Few studies have explored this area, but one group discusses the ability of cranberry proanthocyanins to encourage autophagy in esophageal adenocarcinoma cells via inhibition of the PI3K/AKT/mTOR pathway [122]. Another phenolic compound isolated from a shrub is described to disrupt mTORC1 complex and activate the AMPK/TSC signaling cascade, preventing breast tumor growth [123]. Since mTOR activity is aggressive in tumor development, preventing its bodily dissemination through natural food components seems like a far less intrusive procedure than current cancer therapies. Lastly, bacteria can alter the bioavailability of amino acids through their natural metabolism. They can utilize host-derived amino acids, provide amino acids to the host, or disrupt host pathways involved in amino acid digestion or synthesis [80, 124]. Amino acids, particularly arginine and leucine, are essential for mTORC1 activation [125]. Commensals in the intestine have been reported in utilizing these amino acids for protein synthesis, thereby limiting their availability for host-sensitive pathways [126, 127]. However, amino acid producing bacteria within the human intestine can contribute to this available pool of amino acids [128]. The homeostatic maintenance of the bioavailable pool of amino acids by the gut microbiota may be an important modulator of mTOR activity in vivo, thereby controlling disease development. Still, with the emergence of new mTOR data, we are finding that the list of potential inducers of mTOR to be very extensive. Although arginine and leucine are deemed the most important inducers of mTOR, other amino acids have been found to be able to trigger this pathway, and bacteria that have the ability to disrupt host biochemical pathways can regulate this expression [80, 129]. The complexity of the microbial-host relationship in the context of communal metabolites provides an intricate insight into the regulation of important regulatory pathways.
The reduction of mTOR through pharmaceutical intervention has also been a popular area for research. One drawback to this method is that these techniques aim to directly inhibit this pathway through contact with its key mediators. Although, this seems like the simplest and most effective way to prevent mTOR-mediated disease onset, it could create drastic effects. Since this pathway focuses on essential cellular functions, total inhibition of this pathway could do more harm than good. As these drugs are sometimes not natural chemicals, they can also induce unrelated but potentially critical side effects in the body. The best method of action may be to focus on indirect approaches to modulate mTOR activity, rather than trying to completely prevent its activation. These indirect methods could come in the form of moderating its stimulatory signals, such as inflammation and insulin. As we discover more of the health benefits probiotics have to offer, it is clear that this is a multifaceted interaction with the host. After all, these are living organisms, consuming, excreting, and doing what is necessary to survive rather than a chemical that has no consideration of its existence. It is possible that this complex relationship could be what we need to keep our body in balance. Therefore, the answers to relieving some of today’s most aggressive diseases could come from our own microflora.
This work was funded by the National Institute of Food and Agriculture USDA Grant No. 2015-67017-23182.
Authors declare no conflicts of interest.
Titanium (Ti) is a lustrous metal with a silver color. This metal exists in two different physical crystalline state called body centered cubic (bcc) and hexagonal closed packing (hcp), shown in Figure 1 (a) and (b), respectively. Titanium has five natural isotopes, and these are 46Ti, 47Ti, 48Ti, 49Ti, 50Ti. The 48Ti is the most abundant (73.8%).
\n\nCrystalline state of titanium: (a) bcc, and (b) hcp [8].
Titanium has high strength of 430 MPa and low density of 4.5 g/cm3, compared to iron with strength of 200 MPa and density of 7.9 g/cm3. Accordingly, titanium has the highest strength-to-density ratio than all other metals. However, titanium is quite ductile especially in an oxygen-free environment. In addition, titanium has relatively high melting point (more than 1650°C or 3000°F), and is paramagnetic with fairly low electrical and thermal conductivity. Further, titanium has very low bio-toxicity and is therefore bio-compatible. Furthermore, titanium readily reacts with oxygen at 1200°C (2190°F) in air, and at 610°C (1130°F) in pure oxygen, forming titanium dioxide. At ambient temperature, titanium slowly reacts with water and air to form a passive oxide coating that protects the bulk metal from further oxidation, hence, it has excellent resistance to corrosion and attack by dilute sulfuric and hydrochloric acids, chloride solutions, and most organic acids. However, titanium reacts with pure nitrogen gas at 800°C (1470°F) to form titanium nitride [1, 2].
\nSome of the major areas where titanium is used include the aerospace industry, orthopedics, dental implants, medical equipment, power generation, nuclear waste storage, automotive components, and food and pharmaceutical manufacturing.
\nTitanium is the ninth-most abundant element in Earth‘s crust (0.63% by mass) and the seventh-most abundant metal. The fact that titanium has most useful properties makes it be preferred material of future engineering application. Moreover, the application of titanium can be extended when alloyed with other elements as described below.
\nAn alloy is a substance composed of two or more elements (metals or nonmetals) that are intimately mixed by fusion or electro-deposition. On this basis, titanium alloys are made by adding elements such as aluminum, vanadium, molybdenum, niobium, zirconium and many others to produce alloys such as Ti-6Al-4V and Ti-24Nb-4Zr-8Sn and several others [2]. These alloys have exceptional properties as illustrated below. Depending on their influence on the heat treating temperature and the alloying elements, the alloys of titanium can be classified into the following three types:
\nThese alloys contain a large amount of α-stabilizing alloying elements such as aluminum, oxygen, nitrogen or carbon. Aluminum is widely used as the alpha stabilizer for most commercial titanium alloys because it is capable strengthening the alloy at ambient and elevated temperatures up to about 550°C. This capability coupled with its low density makes aluminum to have additional advantage over other alloying elements such as copper and molybdenum. However, the amount of aluminum that can be added is limited because of the formation of a brittle titanium-aluminum compound when 8% or more by weight aluminum is added. Occasionally, oxygen is added to pure titanium to produce a range of grades having increasing strength as the oxygen level is raised. The limitation of the α alloys of titanium is non-heat treatable but these are generally very weldable. In addition, these alloys have low to medium strength, good notch toughness, reasonably good ductility and have excellent properties at cryogenic temperatures. These alloys can be strengthened further by the addition of tin or zirconium. These metals have appreciable solubility in both alpha and beta phases and as their addition does not markedly influence the transformation temperature they are normally classified as neutral additions. Just like aluminum, the benefit of hardening at ambient temperature is retained even at elevated temperatures when tin and zirconium are used as alloying elements.
\nThese alloys contain 4–6% of β-phase stabilizer elements such as molybdenum, vanadium, tungsten, tantalum, and silicon. The amount of these elements increases the amount of β-phase is the metal matrix. Consequently, these alloys are heat treatable, and are significantly strengthened by precipitation hardening. Solution treatment of these alloys causes increase of β-phase content mechanical strength while ductility decreases. The most popular example of the α-β titanium alloy is the Ti-6Al-4V with 6 and 4% by weight aluminum and vanadium, respectively. This alloy of titanium is about half of all titanium alloys produced. In these alloys, the aluminum is added as α-phase stabilizer and hardener due to its solution strength-ening effect. The vanadium stabilizes the ductile β-phase, providing hot workability of the alloy.
\nThe α-β titanium alloys have high tensile strength, high fatigue strength, high corrosion resistance, good hot formability and high creep resistance [3].
\nTherefore, these alloys are used for manufacturing steam turbine blades, gas and chemical pumps, airframes and jet engine parts, pressure vessels, blades and discs of aircraft turbines, aircraft hydraulic tubing, rocket motor cases, cryogenic parts, and marine components [4].
\nThese alloys exhibit the body centered cubic crystalline form shown in Figure 1 (a). The β stabilizing elements used in these alloy are one or more of the following: molybdenum, vanadium, niobium, tantalum, zirconium, manganese, iron, chromium, cobalt, nickel, and copper. Besides strengthening the beta phase, these β stabilizers lower the resistance to deformation which tends to improve alloy fabricability during both hot and cold working operations. In addition, this β stabilizer to titanium compositions also confers a heat treatment capability which permits significant strengthening during the heat treatment process [4].
\n\nAs a result, the β titanium alloys have large strength to modulus of elasticity ratios that is almost twice those of 18–8 austenitic stainless steel. In addition, these β titanium alloys contain completely biocompatible elements that impart exceptional biochemical properties such as superior properties such as exceptionally high strength-to-weight ratio, low elastic modulus, super-elasticity low elastic modulus, larger elastic deflections, and low toxicity [1, 3].
\nThe above properties make them to be bio-compatible and are excellent prospective materials for manufacturing of bio-implants. Therefore, nowadays these alloys are largely utilized in the orthodontic field since the 1980s, replacing the stainless steel for certain uses, as stainless steel had dominated orthodontics since the 1960s [2].
\nBecause of alloying the titanium achieve improved properties that make it to be preferred material of choice for application in aerospace, medical, marine and instrumentation. The extent of improvement to the properties of titanium alloys and ultimately the choice of area of application is influenced by the methods of production and processing as discussed in the subsequent sections.
\nThe base metal required for production of titanium alloys is pure titanium. Pure titanium is produced using several methods including the Kroll process. This process produces the majority of titanium primary metals used globally by industry today. In this process, the titanium is extracted from its ore rutile—TiO2 or titanium concentrates. These materials are put in a fluidized-bed reactor along with chlorine gas and carbon and heated to 900°C and the subsequent chemical reaction results in the creation of impure titanium tetrachloride (TiCl4) and carbon monoxide. The resultant titanium tetrachloride is fed into vertical distillation tanks where it is heated to remove the impurities by separation using processes such as fractional distillation and precipitation. These processes remove metal chlorides including those of iron, silicon, zirconium, vanadium and magnesium. Thereafter, the purified liquid titanium tetrachloride is transferred to a reactor vessel in which magnesium is added and the container is heated to slightly above 1000°C. At this stage, the argon is pumped into the container to remove the air and prevent the contamination of the titanium with oxygen or nitrogen. During this process, the magnesium reacts with the chlorine to produce liquid magnesium chloride thereby leaving the pure titanium solid. This process is schematically presented in Figure 2.
\nKroll process for production of titanium: (a) chlorination, (b) fractional distillation [5].
The resultant titanium solid is removed from the reactor by boring and then treated with water and hydrochloric acid to remove excess magnesium and magnesium chloride leaving porous titanium sponge, which is jackhammered, crushed, and pressed, followed by melting in a vacuum electric arc furnace using expendable carbon electrode. The melted ingot is allowed to solidify in a vacuum atmosphere. This solid is often remelted to remove inclusions and to homogenize its constituents. These melting steps add to the cost of producing titanium, and this cost is usually about six times that of stainless steel. Usually the titanium solid undergo further treatment to produce titanium powder required in alloying process. The basic methods used to produce titanium powder are summarized below.
\nThe first method is called the Armstrong process, shown in Figure 3, in which the powder is made as the product of extractive processes that produce primary metal powder. This process is capable of producing commercially pure titanium (Ti) powder by the reduction of titanium tetrachloride (TiCl4) and other metal halides using sodium (Na). This process produces powder particles with a unique properties and low bulk density. To improve powder properties such as the particle size distribution and the tap density, additional post processing activities such as dry and wet ball milling are applied. The narrowed particle size distributions are necessary for typical powder metallurgical processes. In addition, the resultant powder’s morphology produced by the Armstrong process provide for excellent compressibility and compaction properties that result in dense compacts with increased green strength than those produced by the irregular powders. For this reason, the powders can even be consolidated by traditional powder metallurgy techniques such as uniaxial compaction and cold isostatic pressing. Figure 4 illustration the scanning electron microscope images of the titanium powders of the Armstrong process. As seen in the figure, the powder has an irregular morphology made of granular agglomerates of smaller particles.
\nIllustration of the Armstrong process [5].
SEM micrographs of CP-Ti produced by Armstrong process [5].
The hydride-dehydride (HDH) process, illustrated in Figure 5, is used to produce titanium powder using titanium sponge, titanium, mill products, or titanium scrap as the raw material. The hydrogenation process is achieved using a batch furnace that is usually operated in vacuum and/or hydrogen atmospheric conditions. The conditions necessary for hydrogenation of titanium are pressure of one atmospheric and temperatures of utmost 800°C. This process results in forming of titanium hydride and alloy hydrides that are usually brittle in nature. These metal hydrides are milled and screened to produce fine powders. The powder is resized using a variety of powder-crushing and milling techniques may be used including: a jaw crusher, ball milling, or jet milling. After the titanium hydride powders are crushed and classified, they are placed back in the batch furnace to dehydrogenate and remove the interstitial hydrogen under vacuum or argon atmosphere and produce metal powder. These powders are irregular and angular in morphology and can also be magnetically screened and acid washed to remove any ferromagnetic contamination. Finer particle sizes can be obtained, but rarely used because oxygen content increases rapidly when the powder is finer than −325 mesh. Powder finer than −325 mesh also possess more safety challenges [5]. The powder can be passivated upon completion of both the hydrogenating and dehydrogenating cycles to minimize exothermic heat generated when exposed to air.
\nHydride-dehydride process for obtaining of titanium powders [6].
The hydride-dehydride process is relatively inexpensive because the hydrogenation and dehydrogenation processes contribute small amount of cost to that of input material. The additional benefit of this process is the fact that the purity of the powder can be very high, as long as the raw material’s impurities are reduced. The oxygen content of final powder has a strong dependence on the input material, the handling processes and the specific surface area of the powder. Therefore, the main disadvantages of hydride-dehydride powder include: the powder morphology is irregular, and the process is not suitable for making virgin alloyed powders or modification of alloy compositions if the raw material is from scrap alloys (Figure 6) [5].
\nSEM micrographs of CP-Ti produced by HDH [5].
Conventional sintering, shown in Figure 7, is one of the widely applied powder metallurgy (PM) based method for manufacturing titanium alloys. In this method, the feedstock titanium powder is mixed thoroughly with alloying elements mentioned in Section 2 using a suitable powder blender, followed by compaction of the mixture under high pressure, and finally sintered. The sintering operation is carried out at high temperature and pressure treatment process that causes the powder particles to bond to each other with minor change to the particle shape, which also allows porosity formation in the product when the temperature is well regulated. This method can produce high performance and low cost titanium alloy parts. The titanium alloy parts produced by powder metallurgy have several advantages such as comparable mechanical properties, near-net-shape, low cost, full dense material, minimal inner defect, nearly homogenous microstructure, good particle-to-particle bonding, and low internal stress compared with those titanium parts produced by other conventional processes [7].
\nPowder metallurgy process [7].
Self-propagating high temperature synthesis (SHS), shown in Figure 8, is another PM based process used to produce titanium alloys. The steps in this process include: mixing of reagents, cold compaction, and finally ignition to initiate a spontaneous self-sustaining exothermic reaction to create the titanium alloy [7].
\nSHS process [7].
Although the above PM processes are mature technologies for fabrication of bone implants they have difficulties of fabricating porous coatings on surfaces that are delicate or with complex geometries. In addition, these processes tend to produce brittle products because of cracks and oxides formed inside the materials. Further, the high costs and poor workability associated with these PM processes restrict their application in commercial production of bone implants. Consequently, new methods, based on additive manufacturing principles were developed [7].
\nThe definitions of advanced methods of production is the use of technological method to improve the quality of the products and/or processes, with the relevant technology being described as “advanced,” “innovative,“ or “cutting edge.” These technologies evolved from conventional processes some of which have been developed to achieve various components of titanium base alloys and aluminides. Atomisation processes are among the most widely used cutting edge methods for production of titanium alloys [5].
\nAtomisation processes are used to make alloyed titanium powders. In these processes, the feedstock material is generally titanium, and the alloy powders produced are further processed typically to manufacture components using processes such as hot isostatic pressing (hip). As mentioned previously, it is generally believed that alloyed powders are not suitable for cold compaction using conventional uniaxial die pressing methods. Moreover, the inherent strength of the alloyed powders is too high, making it difficult to deform the particles in order to achieve desired green density. The atomisation processes produce relatively spherically shaped titanium alloy powders that are most suitable for additive manufacturing using techniques such as selective laser melting or electron beam melting. These spherical powders are also required for manufacturing titanium components using metal injection molding techniques. Typically, additive manufacturing and metal injection molding processes require particle sizes of powders to be in the range of 100 μm to ensure good flowability of the powder during operations. However, the challenge of the atomisation processes usually is that powders produced tend to have a wide particle size distribution, from a few to hundreds of micrometers. Examples of atomisation processes are gas atomisation and plasma atomisation processes described below [5].
\nIn the gas atomisation process, shown in Figure 9, the metal is usually melted using gas and the molten metal is atomised using an inert gas jets. The resultant fine metal droplets are then cooled down during their fall in the atomisation tower. The metal powders obtained by gas-atomization offer a perfectly spherical shape combined with a high cleanliness level. However, even though gas atomisation is, generally, a mature technology, its application need to be widened after addressing a few issues worth noting such as considerable interactions between droplets while they cool during flight in the cooling chamber, causing the formation of satellite particles. Also, due to the erosion of atomising nozzle by the liquid metal, the possibility for contamination by ceramic particles is high. Usually, there may also be argon gas entrapment in the powder that creates unwanted voids [5].
\nSchematic diagrams of gas atomisation process [5].
Plasma atomisation, shown in Figure 10, uses a titanium wire alloy as the feed material which is a significant cost contributing factor. The titanium alloy wire, fed via a spool, is melted in a plasma torch, and a high velocity plasma flow breaks up the liquid into droplets which cool rapidly, with a typical cooling rate in the range of 100–1000°C/s. Plasma atomisation produces powders with particle sizes ranging from 25 to 250 μm. In general, the yield of particles under 45 μm using the plasma wire atomisation technique is significantly higher than that of conventional gas atomisation processes [5].
\nSchematic diagrams of plasma atomisation process [5].
The future methods for production of titanium alloys depend on the demand of these products and to what extend nature will be able to provide them. The demand for titanium alloys shall also influence the number and type of technological breakthroughs, the extent of automation, robotics’ application, the number of discoveries for new titanium alloys, their methods of manufacturing, and new areas of application. Automation is an important aspect of the industry’s future and already a large percentage of the manufacturing processes are fully automated. In addition, automation enables a high level of accuracy and productivity beyond human ability—even in hazardous environments. And while automation eliminates some of the most tedious manufacturing jobs, it is also creating new jobs for a re-trained workforce. The new generation of robotics is not only much easier to program, but also easier to use due to extra capabilities such as voice and image recognition during operations, they are capable of doing precisely what you ask them to do. The discovery of new titanium alloys, or innovative uses of existing ones, is essential for making progress in many of the technological challenges we face. This discovery can result in new synthesis methods of new alloy compounds and design of super alloys, theoretical modeling and even the computational prediction of titanium alloys. This discovery requires that new methods of manufacturing are developed. In light of this, “additive manufacturing” is being developed and this is viewed as a groundbreaking development in manufacturing advancement that offers manufacturers powerful solutions for making any number of products cost-effectively and with little waste. Examples of additive manufacturing technologies are cold spray, 3-D printing, electron beam melting, and selective laser melting. To fabricate alloy surfaces using these technologies, alloying elements are mixed thoroughly in the feedstock powder and the fabrication processes proceed as described in the following paragraphs [7, 8].
\nCold spray (CS) process, schematically shown in Figures 11 and 12 can deposit metals or metal alloys or composite powders on a metallic or dielectric substrate using a high velocity (300–1200 m/s) jet of small (5–50 μm) particles injected in a stream of preheated and compressed gas passing through a specially designed nozzle. The main components of a generic CS system include the source of compressed gas, gas heater, powder feeder, spray nozzle assembly, and sensors for gas pressure and temperature. The source of compressed gas acquires the gas from an external reservoir, compresses it to desired pressure and delivers it into the gas heater. Then, the gas heater preheats the compressed gas in order to increase its enthalpy energy. The preheated gas is delivered into the spray nozzle assembly whose convergent/divergent geometry not only converts the enthalpy energy of the gas into kinetic energy but also mixes the metal powders with the gas proportionately. The powder feeder meters and injects the powder in the spray nozzle assembly. The sensors for the gas pressure and temperature are responsible for regulating the preset pressure and temperature of the gas stream. The powder injection point in the spray nozzle assembly, the gas pressure, and gas temperature distinguish the low pressure-CS system (LP-CS) from the high pressure CS (HP-CS). In the LP-CS system, the feedstock powder is injected in the downstream side of the convergent section of the nozzle assembly, while in the HP-CS system; the powder is injected in the upstream side of the convergent/diverging section of the nozzle assembly as illustrated in Figures 11 and 12. Several other parameters which contribute towards the distinguishing of the CS systems are summarized in Table 1 [8].
\nLow pressure CS process configuration [8].
High pressure CS process configuration [8].
Operation parameters for CS systems [8].
3-D printing is an additive manufacturing method that applies the principle of adding material to create structures using computer aided design (CAD), part modeling, and layer-by-layer deposition of feedstock material. This cutting-edge technology is also called stereolithography, and is illustrated in Figure 13 [8].
\n3D-printing process [8].
In this technology, the pattern is transferred from a digital 3D model, stored in the CAD file, to the object using a laser beam scanned through a reactive liquid polymer which hardened to create a thin layer of the solid. In this manner, the structure is fabricated on the desired surface. This method was proved in the laboratory setup is still being integrated in commercial set-up because 3-D printing is the most widely recognized version of additive manufacturing. For this reason, the inventors and engineers for this process have for years used machines costing anywhere from a few thousand dollars to hundreds of thousands for rapid prototyping of new products. It can be noted that all of the additive-manufacturing processes follow this same basic layer-by-layer deposition principle but with slightly different ways such as using powdered or liquid polymers, metals, metal-alloys or other materials to produce a desired product [8].
\nElectron beam melting (EBM), shown in Figure 14, is one of the additive manufacturing processes which fabricated titanium coatings by melting and deposition of metal powders, layer-by-layer, using a magnetically directed electron beam. Though this method was proved to be successful, it has high set-up costs due to the requirement of high vacuum atmosphere [7].
\nElectron beam melting method [1].
Selective laser melting (SLM), shown in Figure 15 is the second additive manufacturing method for titanium alloy coatings which completely melt the powder using a high-power laser beam. Similarly, this method is costly because it requires advanced high rate cooling systems. Moreover, the fluctuations of temperatures during processing negatively affect the quality of the products [1].
\nSelective laser melting method [1].
This chapter described the titanium as a metal that exists naturally with two crystalline forms. The chapter highlighted the properties of titanium metal that influence its application. The fact that titanium has advantageously unique properties that can be improved by alloying with other elements makes it to be preferred engineering material for future application in such areas as biomedical implants, aerospace, marine structures, and many others. The chapter discussed the traditional, current and future methods necessary to produce structures using titanium and titanium alloys. Further, the chapter suggested “additive manufacturing methods” as advanced methods for future manufacturing because they offer powerful solutions for making any type and number of products cost-effectively and with little waste. The examples of these methods are cold spray, 3-D printing, electron beam melting, and selective laser melting. Finally, the various processes used during fabrication of alloys using these methods were also presented.
\nGeneral requirements for Open Access to Horizon 2020 research project outputs are found within Guidelines on Open Access to Scientific Publication and Research Data in Horizon 2020. The guidelines, in their simplest form, state that if you are a Horizon 2020 recipient, you must ensure open access to your scientific publications by enabling them to be downloaded, printed and read online. Additionally, said publications must be peer reviewed.
',metaTitle:"Horizon 2020 Compliance",metaDescription:"General requirements for Open Access to Horizon 2020 research project outputs are found within Guidelines on Open Access to Scientific Publication and Research Data in Horizon 2020. The guidelines, in their simplest form, state that if you are a Horizon 2020 recipient, you must ensure open access to your scientific publications by enabling them to be downloaded, printed and read online. Additionally, said publications must be peer reviewed. ",metaKeywords:null,canonicalURL:null,contentRaw:'[{"type":"htmlEditorComponent","content":"Publishing with IntechOpen means that your scientific publications already meet these basic requirements. It also means that through our utilization of open licensing, our publications are also able to be copied, shared, searched, linked, crawled, and mined for text and data, optimizing our authors' compliance as suggested by the European Commission.
\\n\\nMetadata for all publications is also automatically deposited in IntechOpen's OAI repository, making them available through the Open Access Infrastructure for Research in Europe's (OpenAIRE) search interface further establishing our compliance.
\\n\\nIn other words, publishing with IntechOpen guarantees compliance.
\\n\\nRead more about Open Access in Horizon 2020 here.
\\n\\nWhich scientific publication to choose?
\\n\\nWhen choosing a publication, Horizon 2020 grant recipients are encouraged to provide open access to various types of scientific publications including monographs, edited books and conference proceedings.
\\n\\nIntechOpen publishes all of the aforementioned formats in compliance with the requirements and criteria established by the European Commission for the Horizon 2020 Program.
\\n\\nAuthors requiring additional information are welcome to send their inquiries to funders@intechopen.com
\\n"}]'},components:[{type:"htmlEditorComponent",content:'Publishing with IntechOpen means that your scientific publications already meet these basic requirements. It also means that through our utilization of open licensing, our publications are also able to be copied, shared, searched, linked, crawled, and mined for text and data, optimizing our authors' compliance as suggested by the European Commission.
\n\nMetadata for all publications is also automatically deposited in IntechOpen's OAI repository, making them available through the Open Access Infrastructure for Research in Europe's (OpenAIRE) search interface further establishing our compliance.
\n\nIn other words, publishing with IntechOpen guarantees compliance.
\n\nRead more about Open Access in Horizon 2020 here.
\n\nWhich scientific publication to choose?
\n\nWhen choosing a publication, Horizon 2020 grant recipients are encouraged to provide open access to various types of scientific publications including monographs, edited books and conference proceedings.
\n\nIntechOpen publishes all of the aforementioned formats in compliance with the requirements and criteria established by the European Commission for the Horizon 2020 Program.
\n\nAuthors requiring additional information are welcome to send their inquiries to funders@intechopen.com
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5228},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10370},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15791}],offset:12,limit:12,total:118192},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"0",sort:"ebgfFaeGuveeFgfcChcyvfu"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:16},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:4},{group:"topic",caption:"Business, Management and Economics",value:7,count:2},{group:"topic",caption:"Chemistry",value:8,count:8},{group:"topic",caption:"Computer and Information Science",value:9,count:6},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:7},{group:"topic",caption:"Engineering",value:11,count:19},{group:"topic",caption:"Environmental Sciences",value:12,count:2},{group:"topic",caption:"Immunology and Microbiology",value:13,count:3},{group:"topic",caption:"Materials Science",value:14,count:5},{group:"topic",caption:"Mathematics",value:15,count:1},{group:"topic",caption:"Medicine",value:16,count:24},{group:"topic",caption:"Neuroscience",value:18,count:2},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:3},{group:"topic",caption:"Psychology",value:21,count:4},{group:"topic",caption:"Robotics",value:22,count:1},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:1}],offset:0,limit:12,total:null},popularBooks:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5240},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9243",title:"Coastal Environments",subtitle:null,isOpenForSubmission:!1,hash:"8e05e5f631e935eef366980f2e28295d",slug:"coastal-environments",bookSignature:"Yuanzhi Zhang and X. San Liang",coverURL:"https://cdn.intechopen.com/books/images_new/9243.jpg",editedByType:"Edited by",editors:[{id:"77597",title:"Prof.",name:"Yuanzhi",middleName:null,surname:"Zhang",slug:"yuanzhi-zhang",fullName:"Yuanzhi Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10020",title:"Operations Management",subtitle:"Emerging Trend in the Digital Era",isOpenForSubmission:!1,hash:"526f0dbdc7e4d85b82ce8383ab894b4c",slug:"operations-management-emerging-trend-in-the-digital-era",bookSignature:"Antonella Petrillo, Fabio De Felice, Germano Lambert-Torres and Erik Bonaldi",coverURL:"https://cdn.intechopen.com/books/images_new/10020.jpg",editedByType:"Edited by",editors:[{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9521",title:"Antimicrobial Resistance",subtitle:"A One Health Perspective",isOpenForSubmission:!1,hash:"30949e78832e1afba5606634b52056ab",slug:"antimicrobial-resistance-a-one-health-perspective",bookSignature:"Mihai Mareș, Swee Hua Erin Lim, Kok-Song Lai and Romeo-Teodor Cristina",coverURL:"https://cdn.intechopen.com/books/images_new/9521.jpg",editedByType:"Edited by",editors:[{id:"88785",title:"Prof.",name:"Mihai",middleName:null,surname:"Mares",slug:"mihai-mares",fullName:"Mihai Mares"}],equalEditorOne:{id:"190224",title:"Dr.",name:"Swee Hua Erin",middleName:null,surname:"Lim",slug:"swee-hua-erin-lim",fullName:"Swee Hua Erin Lim",profilePictureURL:"https://mts.intechopen.com/storage/users/190224/images/system/190224.png",biography:"Dr. Erin Lim is presently working as an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates and is affiliated as an Associate Professor to Perdana University-Royal College of Surgeons in Ireland, Selangor, Malaysia. She obtained her Ph.D. from Universiti Putra Malaysia in 2010 with a National Science Fellowship awarded from the Ministry of Science, Technology and Innovation Malaysia and has been actively involved in research ever since. Her main research interests include analysis of carriage and transmission of multidrug resistant bacteria in non-conventional settings, besides an interest in natural products for antimicrobial testing. She is heavily involved in the elucidation of mechanisms of reversal of resistance in bacteria in addition to investigating the immunological analyses of diseases, development of vaccination and treatment models in animals. She hopes her work will support the discovery of therapeutics in the clinical setting and assist in the combat against the burden of antibiotic resistance.",institutionString:"Abu Dhabi Women’s College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Perdana University",institutionURL:null,country:{name:"Malaysia"}}},equalEditorTwo:{id:"221544",title:"Dr.",name:"Kok-Song",middleName:null,surname:"Lai",slug:"kok-song-lai",fullName:"Kok-Song Lai",profilePictureURL:"https://mts.intechopen.com/storage/users/221544/images/system/221544.jpeg",biography:"Dr. Lai Kok Song is an Assistant Professor in the Division of Health Sciences, Abu Dhabi Women\\'s College, Higher Colleges of Technology in Abu Dhabi, United Arab Emirates. He obtained his Ph.D. in Biological Sciences from Nara Institute of Science and Technology, Japan in 2012. Prior to his academic appointment, Dr. Lai worked as a Senior Scientist at the Ministry of Science, Technology and Innovation, Malaysia. His current research areas include antimicrobial resistance and plant-pathogen interaction. His particular interest lies in the study of the antimicrobial mechanism via membrane disruption of essential oils against multi-drug resistance bacteria through various biochemical, molecular and proteomic approaches. Ultimately, he hopes to uncover and determine novel biomarkers related to antibiotic resistance that can be developed into new therapeutic strategies.",institutionString:"Higher Colleges of Technology",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"8",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Higher Colleges of Technology",institutionURL:null,country:{name:"United Arab Emirates"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9560",title:"Creativity",subtitle:"A Force to Innovation",isOpenForSubmission:!1,hash:"58f740bc17807d5d88d647c525857b11",slug:"creativity-a-force-to-innovation",bookSignature:"Pooja Jain",coverURL:"https://cdn.intechopen.com/books/images_new/9560.jpg",editedByType:"Edited by",editors:[{id:"316765",title:"Dr.",name:"Pooja",middleName:null,surname:"Jain",slug:"pooja-jain",fullName:"Pooja Jain"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9669",title:"Recent Advances in Rice Research",subtitle:null,isOpenForSubmission:!1,hash:"12b06cc73e89af1e104399321cc16a75",slug:"recent-advances-in-rice-research",bookSignature:"Mahmood-ur- Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9669.jpg",editedByType:"Edited by",editors:[{id:"185476",title:"Dr.",name:"Mahmood-Ur-",middleName:null,surname:"Rahman Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-Ur- Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10192",title:"Background and Management of Muscular Atrophy",subtitle:null,isOpenForSubmission:!1,hash:"eca24028d89912b5efea56e179dff089",slug:"background-and-management-of-muscular-atrophy",bookSignature:"Julianna Cseri",coverURL:"https://cdn.intechopen.com/books/images_new/10192.jpg",editedByType:"Edited by",editors:[{id:"135579",title:"Dr.",name:"Julianna",middleName:null,surname:"Cseri",slug:"julianna-cseri",fullName:"Julianna Cseri"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"168",title:"Biomedical Engineering",slug:"medicine-biomedical-engineering",parent:{title:"Medicine",slug:"medicine"},numberOfBooks:23,numberOfAuthorsAndEditors:789,numberOfWosCitations:1214,numberOfCrossrefCitations:521,numberOfDimensionsCitations:1306,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"medicine-biomedical-engineering",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9406",title:"Clinical Implementation of Bone Regeneration and Maintenance",subtitle:null,isOpenForSubmission:!1,hash:"875a140c01518fa7a9bceebd688b0147",slug:"clinical-implementation-of-bone-regeneration-and-maintenance",bookSignature:"Mike Barbeck, Nahum Rosenberg, Patrick Rider, Željka Perić Kačarević and Ole Jung",coverURL:"https://cdn.intechopen.com/books/images_new/9406.jpg",editedByType:"Edited by",editors:[{id:"204918",title:"Dr.",name:"Mike",middleName:null,surname:"Barbeck",slug:"mike-barbeck",fullName:"Mike Barbeck"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9477",title:"Muscular Dystrophy",subtitle:"Research Updates and Therapeutic Strategies",isOpenForSubmission:!1,hash:"dd601de843019d51e1769a26cf7e1acc",slug:"muscular-dystrophy-research-updates-and-therapeutic-strategies",bookSignature:"Gisela Gaina",coverURL:"https://cdn.intechopen.com/books/images_new/9477.jpg",editedByType:"Edited by",editors:[{id:"242747",title:"Dr.",name:"Gisela",middleName:null,surname:"Gaina",slug:"gisela-gaina",fullName:"Gisela Gaina"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8134",title:"Regenerative Medicine",subtitle:null,isOpenForSubmission:!1,hash:"2189275afd996cab432c0f5f7c5869f3",slug:"regenerative-medicine",bookSignature:"Mahmood S Choudhery",coverURL:"https://cdn.intechopen.com/books/images_new/8134.jpg",editedByType:"Edited by",editors:[{id:"187822",title:"Dr.",name:"Mahmood S",middleName:null,surname:"Choudhery",slug:"mahmood-s-choudhery",fullName:"Mahmood S Choudhery"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8093",title:"Xenotransplantation",subtitle:"Comprehensive Study",isOpenForSubmission:!1,hash:"16d2b84272592afd80dd2575eff0546b",slug:"xenotransplantation-comprehensive-study",bookSignature:"Shuji Miyagawa",coverURL:"https://cdn.intechopen.com/books/images_new/8093.jpg",editedByType:"Edited by",editors:[{id:"73965",title:"Prof.",name:"Shuji",middleName:null,surname:"Miyagawa",slug:"shuji-miyagawa",fullName:"Shuji Miyagawa"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7898",title:"Cartilage Tissue Engineering and Regeneration Techniques",subtitle:null,isOpenForSubmission:!1,hash:"cb87bdbe93f1269aae5c6c678c598ce7",slug:"cartilage-tissue-engineering-and-regeneration-techniques",bookSignature:"Dimitrios D. Nikolopoulos, George K. Safos and Kalpaxis Dimitrios",coverURL:"https://cdn.intechopen.com/books/images_new/7898.jpg",editedByType:"Edited by",editors:[{id:"228477",title:"Dr.",name:"Dimitrios D.",middleName:null,surname:"Nikolopoulos",slug:"dimitrios-d.-nikolopoulos",fullName:"Dimitrios D. Nikolopoulos"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7926",title:"Biomaterial-supported Tissue Reconstruction or Regeneration",subtitle:null,isOpenForSubmission:!1,hash:"8a84bfdf7cd30b440b339fc046b155f3",slug:"biomaterial-supported-tissue-reconstruction-or-regeneration",bookSignature:"Mike Barbeck, Ole Jung, Ralf Smeets and Tadas Koržinskas",coverURL:"https://cdn.intechopen.com/books/images_new/7926.jpg",editedByType:"Edited by",editors:[{id:"204918",title:"Dr.",name:"Mike",middleName:null,surname:"Barbeck",slug:"mike-barbeck",fullName:"Mike Barbeck"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6609",title:"Muscle Cell and Tissue",subtitle:"Current Status of Research Field",isOpenForSubmission:!1,hash:"522e700080f9e908b6b330587f0f381d",slug:"muscle-cell-and-tissue-current-status-of-research-field",bookSignature:"Kunihiro Sakuma",coverURL:"https://cdn.intechopen.com/books/images_new/6609.jpg",editedByType:"Edited by",editors:[{id:"195829",title:"Prof.",name:"Kunihiro",middleName:null,surname:"Sakuma",slug:"kunihiro-sakuma",fullName:"Kunihiro Sakuma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6475",title:"Tissue Regeneration",subtitle:null,isOpenForSubmission:!1,hash:"d5ed06a80f0205146aa90d158facefd1",slug:"tissue-regeneration",bookSignature:"Hussein Abdel hay El-Sayed Kaoud",coverURL:"https://cdn.intechopen.com/books/images_new/6475.jpg",editedByType:"Edited by",editors:[{id:"265070",title:"Dr.",name:"Hussein Abdelhay",middleName:null,surname:"Essayed Kaoud",slug:"hussein-abdelhay-essayed-kaoud",fullName:"Hussein Abdelhay Essayed Kaoud"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6052",title:"Cartilage Repair and Regeneration",subtitle:null,isOpenForSubmission:!1,hash:"e4881b3685ffd70f3f4d3d2c49b1d7f6",slug:"cartilage-repair-and-regeneration",bookSignature:"Alessandro R. Zorzi and Joao Batista de Miranda",coverURL:"https://cdn.intechopen.com/books/images_new/6052.jpg",editedByType:"Edited by",editors:[{id:"80871",title:"M.D.",name:"Alessandro Rozim",middleName:null,surname:"Zorzi",slug:"alessandro-rozim-zorzi",fullName:"Alessandro Rozim Zorzi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5952",title:"Xenotransplantation",subtitle:"New Insights",isOpenForSubmission:!1,hash:"903df77921b8704466248d0ff5cbcdd9",slug:"xenotransplantation-new-insights",bookSignature:"Shuji Miyagawa",coverURL:"https://cdn.intechopen.com/books/images_new/5952.jpg",editedByType:"Edited by",editors:[{id:"73965",title:"Prof.",name:"Shuji",middleName:null,surname:"Miyagawa",slug:"shuji-miyagawa",fullName:"Shuji Miyagawa"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4610",title:"Muscle Cell and Tissue",subtitle:null,isOpenForSubmission:!1,hash:"f2719cb06d2a1327298528772eacec55",slug:"muscle-cell-and-tissue",bookSignature:"Kunihiro Sakuma",coverURL:"https://cdn.intechopen.com/books/images_new/4610.jpg",editedByType:"Edited by",editors:[{id:"173502",title:"Dr.",name:"Kunihiro",middleName:null,surname:"Sakuma",slug:"kunihiro-sakuma",fullName:"Kunihiro Sakuma"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4486",title:"Cells and Biomaterials in Regenerative Medicine",subtitle:null,isOpenForSubmission:!1,hash:"1c333e655d47208db36f2a886b49c160",slug:"cells-and-biomaterials-in-regenerative-medicine",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/4486.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",middleName:null,surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:23,mostCitedChapters:[{id:"19013",doi:"10.5772/21983",title:"Cell Responses to Surface and Architecture of Tissue Engineering Scaffolds",slug:"cell-responses-to-surface-and-architecture-of-tissue-engineering-scaffolds",totalDownloads:9689,totalCrossrefCites:107,totalDimensionsCites:227,book:{slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",title:"Regenerative Medicine and Tissue Engineering",fullTitle:"Regenerative Medicine and Tissue Engineering - Cells and Biomaterials"},signatures:"Hsin-I Chang and Yiwei Wang",authors:[{id:"45747",title:"Dr.",name:"Hsin-I",middleName:null,surname:"Chang",slug:"hsin-i-chang",fullName:"Hsin-I Chang"},{id:"53659",title:"Ms.",name:"Yiwei",middleName:null,surname:"Wang",slug:"yiwei-wang",fullName:"Yiwei Wang"}]},{id:"9798",doi:"10.5772/8581",title:"Biomaterial Scaffold Fabrication Techniques for Potential Tissue Engineering Applications",slug:"biomaterial-scaffold-fabrication-techniques-for-potential-tissue-engineering-applications",totalDownloads:14402,totalCrossrefCites:48,totalDimensionsCites:113,book:{slug:"tissue-engineering",title:"Tissue Engineering",fullTitle:"Tissue Engineering"},signatures:"B. Subia, J. Kundu and S. C. Kundu",authors:null},{id:"23660",doi:"10.5772/25476",title:"Scaffolds for Tissue Engineering Via Thermally Induced Phase Separation",slug:"scaffolds-for-tissue-engineering-via-thermally-induced-phase-separation",totalDownloads:6195,totalCrossrefCites:6,totalDimensionsCites:32,book:{slug:"advances-in-regenerative-medicine",title:"Advances in Regenerative Medicine",fullTitle:"Advances in Regenerative Medicine"},signatures:"Carlos A. Martínez-Pérez, Imelda Olivas-Armendariz, Javier S. Castro-Carmona and Perla E. García-Casillas",authors:[{id:"63450",title:"Dr.",name:"Carlos Alberto",middleName:null,surname:"Martínez-Pérez",slug:"carlos-alberto-martinez-perez",fullName:"Carlos Alberto Martínez-Pérez"},{id:"104636",title:"Dr.",name:"Perla E.",middleName:null,surname:"García Casillas",slug:"perla-e.-garcia-casillas",fullName:"Perla E. García Casillas"},{id:"138316",title:"Dr.",name:"Imelda",middleName:null,surname:"Olivas-Armendariz",slug:"imelda-olivas-armendariz",fullName:"Imelda Olivas-Armendariz"},{id:"138317",title:"Dr.",name:"Javier S.",middleName:null,surname:"Castro-Carmona",slug:"javier-s.-castro-carmona",fullName:"Javier S. Castro-Carmona"}]}],mostDownloadedChaptersLast30Days:[{id:"60312",title:"The Role of Extracellular Matrix in Tissue Regeneration",slug:"the-role-of-extracellular-matrix-in-tissue-regeneration",totalDownloads:2209,totalCrossrefCites:5,totalDimensionsCites:15,book:{slug:"tissue-regeneration",title:"Tissue Regeneration",fullTitle:"Tissue Regeneration"},signatures:"Dwi Liliek Kusindarta and Hevi Wihadmadyatami",authors:null},{id:"19013",title:"Cell Responses to Surface and Architecture of Tissue Engineering Scaffolds",slug:"cell-responses-to-surface-and-architecture-of-tissue-engineering-scaffolds",totalDownloads:9692,totalCrossrefCites:109,totalDimensionsCites:227,book:{slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",title:"Regenerative Medicine and Tissue Engineering",fullTitle:"Regenerative Medicine and Tissue Engineering - Cells and Biomaterials"},signatures:"Hsin-I Chang and Yiwei Wang",authors:[{id:"45747",title:"Dr.",name:"Hsin-I",middleName:null,surname:"Chang",slug:"hsin-i-chang",fullName:"Hsin-I Chang"},{id:"53659",title:"Ms.",name:"Yiwei",middleName:null,surname:"Wang",slug:"yiwei-wang",fullName:"Yiwei Wang"}]},{id:"47782",title:"Mass Production of Mesenchymal Stem Cells — Impact of Bioreactor Design and Flow Conditions on Proliferation and Differentiation",slug:"mass-production-of-mesenchymal-stem-cells-impact-of-bioreactor-design-and-flow-conditions-on-prolife",totalDownloads:4515,totalCrossrefCites:8,totalDimensionsCites:15,book:{slug:"cells-and-biomaterials-in-regenerative-medicine",title:"Cells and Biomaterials in Regenerative Medicine",fullTitle:"Cells and Biomaterials in Regenerative Medicine"},signatures:"Valentin Jossen, Ralf Pörtner, Stephan C. Kaiser, Matthias Kraume,\nDieter Eibl and Regine Eibl",authors:[{id:"52441",title:"Prof.",name:"Dieter",middleName:null,surname:"Eibl",slug:"dieter-eibl",fullName:"Dieter Eibl"},{id:"171203",title:"Prof.",name:"Ralf",middleName:null,surname:"Pörtner",slug:"ralf-portner",fullName:"Ralf Pörtner"},{id:"171347",title:"Prof.",name:"Regine",middleName:null,surname:"Eibl",slug:"regine-eibl",fullName:"Regine Eibl"},{id:"171348",title:"M.Sc.",name:"Valentin",middleName:null,surname:"Jossen",slug:"valentin-jossen",fullName:"Valentin Jossen"}]},{id:"34830",title:"Augmentation and Preservation of the Alveolar Process and Alveolar Ridge of Bone",slug:"augmentation-and-preservation-of-the-alveolar-process-and-alveolar-ridge-of-bone",totalDownloads:7854,totalCrossrefCites:3,totalDimensionsCites:6,book:{slug:"bone-regeneration",title:"Bone Regeneration",fullTitle:"Bone Regeneration"},signatures:"Haim Tal, Zvi Artzi, Roni Kolerman, Ilan Beitlitum and Gal Goshen",authors:[{id:"97351",title:"Prof.",name:"Haim",middleName:null,surname:"Tal",slug:"haim-tal",fullName:"Haim Tal"},{id:"128141",title:"Prof.",name:"Zvi",middleName:null,surname:"Artzi",slug:"zvi-artzi",fullName:"Zvi Artzi"},{id:"129173",title:"Dr.",name:"Roni",middleName:null,surname:"Kolerman",slug:"roni-kolerman",fullName:"Roni Kolerman"},{id:"129175",title:"Dr.",name:"Ilan",middleName:null,surname:"Beitelthum",slug:"ilan-beitelthum",fullName:"Ilan Beitelthum"},{id:"129176",title:"Dr.",name:"Gal",middleName:null,surname:"Goshen",slug:"gal-goshen",fullName:"Gal Goshen"}]},{id:"9794",title:"High Resolution X-Ray Tomography - 3D Imaging for Tissue Engineering Applications",slug:"high-resolution-x-ray-tomography-3d-imaging-for-tissue-engineering-applications",totalDownloads:3678,totalCrossrefCites:2,totalDimensionsCites:2,book:{slug:"tissue-engineering",title:"Tissue Engineering",fullTitle:"Tissue Engineering"},signatures:"Zehbe Rolf, Haibel Astrid, Schmidt Franziska, Riesemeier Heinrich, Kirkpatrick C. James, Schubert Helmut and Brochhausen Christoph",authors:null},{id:"44652",title:"Tissue Engineered Animal Sparing Models for the Study of Joint and Muscle Diseases",slug:"tissue-engineered-animal-sparing-models-for-the-study-of-joint-and-muscle-diseases",totalDownloads:1931,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"regenerative-medicine-and-tissue-engineering",title:"Regenerative Medicine and Tissue Engineering",fullTitle:"Regenerative Medicine and Tissue Engineering"},signatures:"Ali Mobasheri and Mark Lewis",authors:[{id:"53525",title:"Prof.",name:"Ali",middleName:null,surname:"Mobasheri",slug:"ali-mobasheri",fullName:"Ali Mobasheri"},{id:"163371",title:"Prof.",name:"Mark",middleName:null,surname:"Lewis",slug:"mark-lewis",fullName:"Mark Lewis"}]},{id:"65590",title:"Current Tissue Engineering Approaches for Cartilage Regeneration",slug:"current-tissue-engineering-approaches-for-cartilage-regeneration",totalDownloads:1239,totalCrossrefCites:6,totalDimensionsCites:9,book:{slug:"cartilage-tissue-engineering-and-regeneration-techniques",title:"Cartilage Tissue Engineering and Regeneration Techniques",fullTitle:"Cartilage Tissue Engineering and Regeneration Techniques"},signatures:"He Huang, Hongyao Xu and Jianying Zhang",authors:[{id:"274274",title:"Associate Prof.",name:"Jianying",middleName:null,surname:"Zhang",slug:"jianying-zhang",fullName:"Jianying Zhang"},{id:"290437",title:"Dr.",name:"He",middleName:null,surname:"Huang",slug:"he-huang",fullName:"He Huang"},{id:"290447",title:"Dr.",name:"Hongyao",middleName:null,surname:"Xu",slug:"hongyao-xu",fullName:"Hongyao Xu"}]},{id:"65513",title:"Innovative Biomaterials for Tissue Engineering",slug:"innovative-biomaterials-for-tissue-engineering",totalDownloads:942,totalCrossrefCites:1,totalDimensionsCites:6,book:{slug:"biomaterial-supported-tissue-reconstruction-or-regeneration",title:"Biomaterial-supported Tissue Reconstruction or Regeneration",fullTitle:"Biomaterial-supported Tissue Reconstruction or Regeneration"},signatures:"Anna Dolcimascolo, Giovanna Calabrese, Sabrina Conoci and Rosalba Parenti",authors:[{id:"272544",title:"Prof.",name:"Rosalba",middleName:null,surname:"Parenti",slug:"rosalba-parenti",fullName:"Rosalba Parenti"},{id:"273282",title:"Dr.",name:"Anna",middleName:null,surname:"Dolcimascolo",slug:"anna-dolcimascolo",fullName:"Anna Dolcimascolo"},{id:"273283",title:"Dr.",name:"Giovanna",middleName:null,surname:"Calabrese",slug:"giovanna-calabrese",fullName:"Giovanna Calabrese"},{id:"283275",title:"Dr.",name:"Sabrina",middleName:null,surname:"Conoci",slug:"sabrina-conoci",fullName:"Sabrina Conoci"}]},{id:"66180",title:"Application of Bone Substitutes and Its Future Prospective in Regenerative Medicine",slug:"application-of-bone-substitutes-and-its-future-prospective-in-regenerative-medicine",totalDownloads:898,totalCrossrefCites:1,totalDimensionsCites:3,book:{slug:"biomaterial-supported-tissue-reconstruction-or-regeneration",title:"Biomaterial-supported Tissue Reconstruction or Regeneration",fullTitle:"Biomaterial-supported Tissue Reconstruction or Regeneration"},signatures:"Ujjwal Ranjan Dahiya, Sarita Mishra and Subia Bano",authors:[{id:"126760",title:"Prof.",name:"Bano",middleName:null,surname:"Subia",slug:"bano-subia",fullName:"Bano Subia"},{id:"272470",title:"Dr.",name:"Ujjwal",middleName:null,surname:"Dahiya",slug:"ujjwal-dahiya",fullName:"Ujjwal Dahiya"},{id:"272471",title:"Dr.",name:"Sarita",middleName:null,surname:"Mishra",slug:"sarita-mishra",fullName:"Sarita Mishra"}]},{id:"44120",title:"Naturally Derived Biomaterials: Preparation and Application",slug:"naturally-derived-biomaterials-preparation-and-application",totalDownloads:5584,totalCrossrefCites:10,totalDimensionsCites:15,book:{slug:"regenerative-medicine-and-tissue-engineering",title:"Regenerative Medicine and Tissue Engineering",fullTitle:"Regenerative Medicine and Tissue Engineering"},signatures:"Tran Le Bao Ha, To Minh Quan, Doan Nguyen Vu and Do Minh Si",authors:[{id:"159197",title:"Ph.D.",name:"Tran",middleName:null,surname:"Le Bao Ha",slug:"tran-le-bao-ha",fullName:"Tran Le Bao Ha"},{id:"166753",title:"MSc.",name:"To Minh",middleName:null,surname:"Quan",slug:"to-minh-quan",fullName:"To Minh Quan"},{id:"166757",title:"BSc.",name:"Doan",middleName:null,surname:"Nguyen Vu",slug:"doan-nguyen-vu",fullName:"Doan Nguyen Vu"},{id:"166760",title:"Dr.",name:"Do",middleName:null,surname:"Minh Si",slug:"do-minh-si",fullName:"Do Minh Si"}]}],onlineFirstChaptersFilter:{topicSlug:"medicine-biomedical-engineering",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"profile.detail",path:"/profiles/98139/luiz-affonso-guedes",hash:"",query:{},params:{id:"98139",slug:"luiz-affonso-guedes"},fullPath:"/profiles/98139/luiz-affonso-guedes",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()